DEF 14A

Date & Time:

May 8, 2024

Record Date:

March 21, 2024

10:00 a.m. ET

You may vote if you were a shareholder at the close of business on March 21, 2024. A list of Record Date holders will be available during ordinary business hours, at our principal place of business in Orlando, Florida for a period of 10 days ending on the day before May 8, 2024, the Annual Meeting date.

www.proxypush.com/PCT

Proxy Mail Date:

March 28, 2024

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

SCHEDULE 14A

(Rule

14a-101)

INFORMATION REQUIRED IN PROXY STATEMENT

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No. )

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

☐	Preliminary Proxy Statement

☐	Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

☒	Definitive Proxy Statement

☐	Definitive Additional Materials

☐	Soliciting Material under §240.14a-12

PureCycle Technologies, Inc.

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check all boxes that apply):

☒	No fee required

☐	Fee paid previously with preliminary materials

☐	Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

MESSAGE FROM THE CHIEF EXECUTIVE OFFICER

Dear Fellow PureCycle Shareholders,

We are pleased to invite you to join us at the 2024 annual meeting of shareholders (the “Annual Meeting”) of PureCycle Technologies, Inc. (the “Company”, “we”, “our”, “PureCycle”, or “PCT”) to be held on May 8, 2024, at 10:00 a.m. Eastern Time by means of a live virtual conference. We value your voice and believe it is important that your shares are represented at our Annual Meeting. We urge you to cast your vote as soon as possible by telephone, via the Internet or by mail.

The following notice of the annual meeting (the “Notice of Availability” or “Notice”) and proxy statement (the “Proxy Statement” or “Proxy”) describe the various matters that will be voted on. During the meeting, we will also provide a corporate update and open the floor for you to ask questions related to this update and other PureCycle-related matters.

Please refer to the accompanying Proxy Statement for detailed information on each of the proposals and the Annual Meeting.

On behalf of the Board of Directors, executives and all PureCycle team members, we appreciate your continued support of PureCycle and the work we do to take on the plastic waste crisis.

March 28, 2024

LOGO

Dustin Olson

Chief Executive Officer

NOTICE OF 2024 ANNUAL GENERAL MEETING -

2024 Annual General Meeting of Shareholders Details

For additional Annual Meeting details, please see “General Information About the Annual Meeting and Voting” in this Proxy Statement.

Voting: Shareholders are invited to attend the live virtual meeting. Even if you plan to attend, we encourage you to vote in advance of the meeting. You may cast your vote via:

Internet

www.proxypush.com/PCT

Mail

mark, sign, date & return your proxy card

Phone

1 (866) 396-2053

Live @ virtual Annual Meeting

www.proxydocs.com/PCT

Please see “How to Vote” below for specific instructions on how to vote through each of these channels.

At our Annual Meeting, our shareholders will be asked to:

Elect the seven directors recommended by our Nominating and Corporate Governance (“N&CG”) Committee, approved by our Board, and named in this Proxy Statement;

Ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024;

Approve, on an advisory basis, our named executive officer compensation; and

Transact any other business that may properly come before the Annual Meeting or any adjournment or postponement thereof.

Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting To be Held on May 8, 2024: Our Annual Report on Form 10-K for the year ended December 31, 2023, and the 2024 Proxy Statement are available free of charge at: www.proxydocs.com/PCT.

By order of the Board of Directors,

LOGO

Brad S. Kalter

General Counsel and Corporate Secretary

TABLE OF CONTENTS


	Page
NOTICE OF 2024 ANNUAL GENERAL MEETING		i

GENERAL INFORMATION ABOUT THE ANNUAL MEETING AND VOTING		1

PROPOSAL ONE — ELECTION OF DIRECTORS		6

BOARD OF DIRECTORS AND EXECUTIVE OFFICERS		7

Director Nominees and Qualifications		7

Current Executive Officers		9

Director Compensation		9

CORPORATE GOVERNANCE		12

Governance Overview		12

Board Independence		13

Leadership Structure		13

Board Role in Risk Oversight		14

Board Committees and Meetings		14

Board Composition and Refreshment		17

Related Party Policy and Transactions		19

PROPOSAL TWO — RATIFY GRANT THORNTON LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2024		22

AUDIT AND FINANCE COMMITTEE REPORT		24

PROPOSAL THREE — ADVISORY APPROVAL OF NAMED EXECUTIVE OFFICER COMPENSATION		26

EXECUTIVE COMPENSATION		27

Compensation Discussion and Analysis		27

Compensation Committee Interlocks and Insider Participation		40

Compensation Committee Report		40

Compensation Tables		41

Potential Payments Upon Termination or Change in Control		45

Securities Authorized for Issuance Under Equity Compensation Plans		48

CEO Pay Ratio		49

Pay versus Performance		50

OTHER MATTERS		53

Stock Ownership of Major Shareholders, Executive Officers and Directors		53

Delinquent Section 16(a) Reports		55

Other Proxy Information		56

Forward-looking statements. Except for historical and factual information contained herein, matters set forth in this Proxy Statement identified by words such as “expects,” “believes,” “will” and similar expressions are forward-looking statements under the Securities Act of 1933, as amended (the “Securities Act”), and the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and are subject to the “safe harbor” protection thereunder. These forward-looking statements are not guarantees of future results and are based on current expectations only and are subject to uncertainties. These risks and uncertainties include, but are not limited to, the risks detailed in the Company’s filings with the Securities and Exchange Commission (the “SEC”), including the “Risk Factors” section of our Annual Report on Form 10-K for the fiscal year ended December 31, 2023. Actual events and results may differ materially from those anticipated by us in those statements due to several factors, including those disclosed in our other filings with the SEC. We may change our intentions or plans discussed in our forward-looking statements without notice at any time and for any reason.

GENERAL INFORMATION ABOUT THE ANNUAL MEETING AND VOTING

Purpose of the Annual Meeting. At our Annual Meeting, our shareholders will be asked to consider and vote on the following proposals:

Proposal 1:

Elect the seven directors recommended by our N&CG Committee, approved by our Board, and named in this Proxy Statement;

Proposal 2:

Ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024; and

Proposal 3:

Approve, on an advisory basis, our named executive officer compensation;

As of the date of this Proxy Statement, we are not aware of any business to come before the Annual Meeting other than the three items noted above.

Board of Directors Recommendation. Our Board of Directors unanimously recommends that you vote:

FOR

the proposal to Elect the seven directors recommended by our N&CG Committee, approved by our Board, and named in this Proxy Statement;

FOR

the proposal to Ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024; and

FOR

the advisory resolution to Approve named executive officer compensation

Availability of Proxy Materials. The Proxy materials, including this Proxy Statement, a Proxy card and our Annual Report on Form 10-K for the year ended December 31, 2023, which we filed with the SEC on March 6, 2024 (the “2023 Annual Report”), are available for viewing, printing and downloading at www.proxydocs.com/PCT.

Who Can Vote at the Annual Meeting? Only shareholders of record at the close of business on the Record Date of March 21, 2024, are entitled to receive notice of the Annual Meeting and to vote the shares of our common stock that they held on that date. As of the Record Date, there were 164,444,265 shares of our common stock issued and outstanding. Each share of common stock is entitled to one vote on each matter properly brought before the Annual Meeting.

Difference Between a “Shareholder of Record” and a Beneficial Owner of Shares Held in “Street Name.”

Shareholder of Record. If your shares are registered directly in your name with our transfer agent, Continental Transfer & Trust Company, then you are considered the “shareholder of record” of those shares. In this case, your Notice of Availability has been sent to you directly by us. You may vote your shares by proxy prior to the Annual Meeting by following the instructions contained in the Notice of Availability and in the section titled “How to Vote” below.

Beneficial Owner of Shares Held in Street Name. If your shares are held by a bank, broker or other nominee, then you are considered the beneficial owner of those shares, which are held in “street name.” In this case, your Notice of Availability will be sent to you by that organization. The organization holding your shares is considered the shareholder of record for purposes of voting at the Annual Meeting. As the beneficial owner, you have the right to instruct that organization as to how to vote the shares held in your account by following the instructions contained on the voting instruction card provided to you by that organization.

Why Did I Receive a Notice in the Mail Regarding the Internet Availability of Proxy Materials instead of a Full Set of Proxy Materials? We are pleased to comply with the rules of the SEC that allow companies to distribute their proxy materials over the Internet under the “notice and access” approach. As a result, we are sending the shareholders of record and the beneficial owners of our common stock a copy of the Notice of

Availability instead of paper copies of this Proxy Statement, our Proxy card, and our 2023 Annual Report. We will send the Notice of Availability on or prior to March 28, 2024. Detailed instructions on how to access these materials via the Internet may be found in the Notice of Availability. This Proxy Statement and our 2023 Annual Report are available for viewing, printing and downloading on the Internet at www.proxydocs.com/PCT.

How to Virtually Attend the Annual Meeting. The Annual Meeting will be a virtual meeting and you may not attend in person. In order to attend the meeting online, you must register in advance at www.proxydocs.com/PCT prior to the deadline of May 7, 2024, at 11:59 p.m., Eastern Time. You may attend the Annual Meeting online by following the instructions that you will receive once your registration is complete.

Online registration for the Annual Meeting will begin on March 28, 2024, and you should allow ample time for the online registration. Upon completing your registration, you will receive a verification email confirming your registration into the Annual Meeting. The Annual Meeting will start at 10:00 a.m., Eastern Time, on May 8, 2024. You will receive a link to join the Annual Meeting one hour prior to the start of the meeting, and you will be allowed to “enter” the Annual Meeting through the link 15 minutes prior to the meeting. We will have technicians standing by and ready to assist you with any technical difficulties you may have accessing the virtual meeting starting at 9:45 a.m., Eastern Time, on May 8, 2024.

How to Vote. If you are the shareholder of record of your shares as of the Record Date, you can vote your shares by proxy prior to the Annual Meeting or online during the Annual Meeting. If you choose to vote by proxy prior to the Annual Meeting, you may do so by telephone, via the Internet or by mail as follows:

•

By Telephone Prior to the Annual Meeting. You may transmit your proxy over the phone by calling (866) 396-2053 and following the instructions provided in the Notice of Availability and on the proxy card. You will need to have your Notice of Availability or proxy card in hand when you call.

•

Via the Internet Prior to the Annual Meeting. You may transmit your proxy via the Internet by following the instructions provided in the Notice of Availability and on the proxy card. You will need to have your Notice of Availability or proxy card in hand when you access the website. The website for voting is available at www.proxypush.com/PCT.

•

By Mail Prior to the Annual Meeting. If you requested printed copies of proxy materials, you may vote by mailing your proxy card as described in the proxy materials.

•

Online during the Annual Meeting. In order to attend the Annual Meeting online and vote online during the Annual Meeting, you must register in advance at www.proxydocs.com/PCT prior to the deadline of May 7, 2024, at 11:59 p.m. Eastern Time. You may vote your shares online while virtually attending the Annual Meeting by following the instructions found on your Notice, proxy card and/or voting instruction form and subsequent instructions that will be delivered to you via email following your registration.

Telephone and Internet voting for shareholders of record will be available until 10:00 a.m. Eastern Time on May 8, 2024, and mailed proxy cards must be received by 10:00 a.m. Eastern Time on May 8, 2024, in order to be counted at the Annual Meeting.

If your shares are held in street name, your bank, broker or other nominee is required to vote the shares it holds on your behalf according to your instructions. The proxy materials, as well as voting and revocation instructions, should have been forwarded to you by the bank, broker or other nominee that holds your shares. In order to vote your shares you will need to follow the instructions that your bank, broker or other nominee provides you. The voting deadlines and availability of telephone and Internet voting for beneficial owners of shares held in “street name” will depend on the voting processes of the bank, broker or other nominee that holds your shares. Therefore, we urge you to carefully review and follow the voting instruction card and any other materials that you receive from that organization. If your shares are held in “street name,” you must demonstrate proof of beneficial ownership to virtually attend the Annual Meeting and must obtain a legal proxy from your bank,

broker or other nominee to vote at the Annual Meeting. Only shareholders who have registered to attend the meeting by May 7, 2024, at 11:59 p.m. Eastern Time, using the process described above may vote during the meeting. In addition, you will need your control number included on your Notice, proxy card or voting instruction form in order to demonstrate proof of beneficial ownership and to be able to vote during the Annual Meeting.

Even if you plan to attend the Annual Meeting online, we urge you to vote your shares by proxy in advance of the Annual Meeting so that if you should become unable to attend the Annual Meeting your shares will be voted as directed by you.

Can I Vote My Shares by Filling Out and Returning the Notice of Internet Availability of Proxy Materials? No. The Notice of Availability and proxy card contain instructions on how to vote by proxy via the Internet, by telephone, by requesting and returning a paper proxy card, or by voting online while virtually attending the Annual Meeting.

How Do I Submit a Question at the Annual Meeting? Shareholders can submit questions while registering to attend the virtual meeting and may continue to so at any time prior to or during the Annual Meeting until its adjournment.

May I See a List of Shareholders Entitled to Vote as of the Record Date? A list of shareholders as of the close of business on the Record Date will be available for examination by the shareholders at our principal place of business in Orlando, Florida for a period of ten days ending on the day before May 8, 2024, the Annual Meeting date.

Quorum. A quorum of shareholders is necessary to hold a valid meeting. Our Second Amended and Restated Bylaws (“Bylaws”) provide that a quorum will exist if shareholders holding a majority of the shares of stock issued and outstanding and entitled to vote at the meeting are present at the meeting in person or by means of remote communication or represented by proxy. The inspector of elections determines whether quorum is present.

Shares present virtually during the Annual Meeting will be considered shares of common stock represented in person or by means of remote communication at the meeting. If a quorum is not present, we expect to adjourn the Annual Meeting until a quorum is obtained.

A broker “non-vote” occurs when (i) a broker or other nominee holds shares for a beneficial owner, (ii) the beneficial owner has not given the respective broker specific voting instructions, (iii) the matter is non-routine in nature, and (iv) there is at least one routine proposal presented at the applicable meeting of shareholders (such as Proposal 2 at this Annual Meeting). Under applicable rules, a broker or other nominee has discretionary voting power only with respect to proposals that are considered “routine,” but not with respect to “non-routine” proposals. Broker non-votes are considered present for purposes of determining the presence of a quorum so long as the shares represented by a broker or other nominee who holds shares for a beneficial owner, where the beneficial owner has not given the respective broker or other nominee specific voting instructions, can be voted for, against or in abstention for at least one proposal presented at the Annual Meeting. Because there is a routine proposal presented at the Annual Meeting (Proposal 2) on which brokers and other nominees have such discretionary voting power, broker non-votes will be counted for quorum purposes at the Annual Meeting.

Abstentions represent a shareholder’s affirmative choice to decline to vote on a proposal and occur when shares present at the meeting are marked ABSTAIN.

Proposals 1 and 3 are non-routine matters, so your broker or nominee may not vote your shares on Proposal 1 or Proposal 3 without your instructions. Proposal 2, the ratification of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024, is a routine matter so your broker or nominee may vote your shares on Proposal 2 even in the absence of your instruction.

Please instruct your bank, broker or other nominee to ensure that your vote will be counted.

Votes Required. With respect to Proposal 1, directors shall be elected by the affirmative vote of the majority of the votes cast (meaning the number of shares voted “for” a nominee must exceed the number of shares voted “against” such nominee). If any nominee for director receives a greater number of votes “against” his or her election than votes “for” such election, our Bylaws require that such person must promptly tender his or her resignation to the Board following certification of the vote. Such tendered resignation will be considered in accordance with the procedures set forth in our Bylaws. Abstentions and broker non-votes are not considered votes cast for the foregoing purpose, and will have no effect on the election of nominees.

Adoption of each of Proposals 2 and 3 requires the affirmative vote of the holders of a majority of shares present in person or represented by proxy and entitled to vote on the matter (meaning that of the shares present or represented at the meeting and entitled to vote, a majority of them must be voted “for” the proposal for it to be approved). Abstentions will have the same effect as a vote “against” Proposals 2 and 3. Proposal 2 is considered a routine matter on which the broker will have discretionary authority to vote on the proposal should a beneficial holder not provide voting instructions. For that reason, if you are a beneficial holder and you wish to vote “for,” “against” or “abstain” from Proposal 2, you will have to provide your broker with such an instruction. Otherwise, your broker will vote Proposal 2 in its discretion. Broker non-votes will have no effect on the vote for Proposal 3.

How You May Vote. With respect to Proposal 1 you may vote “for” or “against” each of nominees, or you may “abstain” from voting for one or more nominees. If you “abstain” from voting with respect to Proposal 1, your vote will not be considered a vote cast for Proposal 1 and will have no effect on the election of nominees. Broker non-votes will have no effect on the election of the nominees.

With respect to each of Proposals 2 and 3, you may vote “for,” “against” or “abstain.” If you “abstain” from voting with respect to Proposal 2 or Proposal 3, your vote will have the same effect as a vote “against” that proposal. Proposal 2 is considered a routine matter on which the broker will have discretionary authority to vote on the proposal should a beneficial holder not provide voting instructions. For that reason, if you are a beneficial holder and you wish to vote “for,” “against” or “abstain” from Proposal 2, you will have to provide your broker with such an instruction. Otherwise, your broker will vote Proposal 2 in its discretion. Broker non-votes will have no effect on the vote for Proposal 3.

Method of Counting Votes. Each holder of common stock is entitled to one vote at the Annual Meeting on each matter to come before the Annual Meeting, including the election of directors, for each share held by such shareholder as of the Record Date. Votes cast online during the Annual Meeting or by proxy by mail, via the Internet or by telephone will be tabulated by the inspector of elections appointed for the Annual Meeting, who will also determine whether a quorum is present.

Revoking a Proxy; Changing Your Vote. If you are a shareholder of record, you may revoke your proxy before the vote is taken at the Annual Meeting:

•

by submitting a new proxy with a later date before the applicable deadline either signed and returned by mail or transmitted using the telephone or Internet voting procedures described in the “How to Vote” section above;

•

by voting online at the Annual Meeting using the procedures described in the “How to Vote” section above; or

•

by filing a written revocation with our Corporate Secretary which must be received before 5:00 p.m. Eastern Time on May 7, 2024.

If your shares are held in “street name,” you may submit new voting instructions by contacting your bank, broker or other nominee holding your shares. You may also vote online during the Annual Meeting, which will have the effect of revoking any previously submitted voting instructions, if you obtain a legal proxy from the organization that holds your shares and follow the procedures described in the “How to Vote” section above.

Your virtual attendance at the Annual Meeting, without voting online during the Annual Meeting, will not automatically revoke your proxy.

Costs of Proxy Solicitation. We will pay the cost of soliciting proxies. The Company is making this solicitation by mail and may also use telephone or in person contacts, using the services of a number of regular employees of PureCycle at nominal or no cost. Brokerage houses, nominees, custodians and fiduciaries will be requested to forward soliciting material to beneficial owners of common stock held of record by them, and we will reimburse those persons for their reasonable expenses in doing so.

Voting Results. We plan to announce preliminary voting results at the Annual Meeting and will publish final results in a Current Report on Form 8-K to be filed with the SEC within four business days following the Annual Meeting.

2025 Shareholder Proposals and Nominations. In order to submit a proposal for inclusion in our proxy statement and proxy card for the 2025 annual meeting of shareholders, you must follow the procedures outlined in Rule 14a-8 of the Exchange Act. To be eligible for inclusion, we must receive your shareholder proposal at our principal corporate offices in Orlando, Florida as set forth below no later than November 28, 2024.

If you wish to present a proposal or nominate a director for consideration at the 2025 annual meeting of shareholders without having the proposal or nominee included in our proxy statement and proxy card per the above paragraph, you must follow the current advance notice provisions and other requirements and procedures outlined in our Bylaws, which are filed with the SEC. To be properly brought, that notice must contain the information specified in our Bylaws and we must receive your notice at the address noted below no earlier than the close of business on January 9, 2025, and no later than the close of business on February 8, 2025. If your notice is not properly brought before the 2025 annual meeting of shareholders in accordance with our Bylaws, the chairman of the Board of Directors may declare such proposal or nomination not properly brought before the 2025 annual meeting of shareholders, and it will not be acted upon.

Universal Proxy Rules. In addition to satisfying the requirements under our Bylaws, if a shareholder intends to comply with the SEC’s universal proxy rules and to solicit proxies in support of director nominees other than the Company’s nominees, the shareholder must provide notice that sets forth the information required by Rule 14a-19 under the Exchange Act, which notice—unless the information required by Rule 14a-19 has been provided in a preliminary or definitive proxy statement previously filed by such shareholder—must be postmarked or transmitted electronically to us at our principal executive offices no later than 60 calendar days prior to the one-year anniversary date of the Annual Meeting (for the 2025 Annual Meeting of Shareholders, no later than March 9, 2025). If the date of the 2025 Annual Meeting is changed by more than 30 calendar days from such anniversary date, however, then the shareholder must provide notice by the later of 60 calendar days prior to the date of the 2025 Annual Meeting and the 10th calendar day following the date on which public announcement of the date of the 2025 Annual Meeting is first made.

As of the deadline for shareholders to provide notice of such intent pursuant to Rule 14a-19 for the Annual Meeting, no shareholder provided such notice and, consequently, the universal proxy rules do not apply to this Annual Meeting.

Any proposals or notices should be sent to the following mailing address:

Brad S. Kalter

General Counsel and Corporate Secretary

PureCycle Technologies, Inc.

5950 Hazeltine National Drive, Suite 300

Orlando, Florida 32822

PROPOSAL ONE — ELECTION OF DIRECTORS

The following seven directors have been recommended by our N&CG Committee and approved by our Board. The nominees will serve for a one year term until the 2025 annual meeting of shareholders and until their successors are duly elected and qualified or until their earlier death, disability, resignation, disqualification or removal. The Board expects each nominee to be able to serve if elected.

Vote Required

Each of the seven director nominees will be elected by the affirmative vote of the majority of the votes cast (meaning the number of shares voted “for” a nominee must exceed the number of shares voted “against” such nominee). If any nominee for director receives a greater number of votes “against” his or her election than votes “for” election, our Bylaws require that such person must promptly tender his or her resignation to the Board following certification of the vote. Such tendered resignation will be considered in accordance with the procedures set forth in our Bylaws.

Abstentions and broker non-votes are not considered votes cast for the foregoing purpose and will have no effect on the election of nominees.

Vote Recommendation: “FOR” the election of each of the seven nominees for election to the Board.

BOARD OF DIRECTORS AND EXECUTIVE OFFICERS

Director Nominees and Qualifications

Steven Bouck, 67, joined the Board in 2022. He is an independent director, Chair of the Compensation Committee and member of the Audit and Finance Committee. Mr. Bouck served as the Executive Projects Manager for Waste Connections, Inc., a solid waste services company, from July 2018 until March 2022. Prior to that, Mr. Bouck served in executive leadership roles with Waste Connections as President, from September 2004 to July 2018, and as Executive Vice President and Chief Financial Officer, from February 1998 to September 2004. Mr. Bouck held various positions with First Analysis Corporation, an investment research and private equity firm, from 1986 to 1998, focusing on financial services to the environmental industry. Mr. Bouck holds B.S. and M.S. degrees in Mechanical Engineering from Rensselaer Polytechnic Institute, and a Masters in Business Administration in Finance from the Wharton School of Business. The Company believes that Mr. Bouck is well qualified to serve as a member of the Board due to his corporate leadership experience, particularly in the environmental industry.

Tanya Burnell, 47, joined the Board in 2021. She is an independent director, Chair of the Audit and Finance Committee and a member of the Compensation Committee. Since 2021, Ms. Burnell has served as Vice President, Growth Equity and Sustainability, of CC Industries, Inc., an affiliate of Henry Crown and Company, a privately owned investment company. From 2013 to 2021, Ms. Burnell served as a Director of CC Industries, Inc. In her role, Ms. Burnell focuses primarily on sourcing and executing new investment opportunities, and providing strategic, financial and operational oversight to operating companies. Previously, Ms. Burnell was a Director and Co-Head of Corporate Development for UL Solutions, a global safety science company, and held various positions in the Investment Banking Division of Citigroup, a global financial institution. Ms. Burnell holds a Bachelor of Science in Business Administration from the University of Richmond, and a Master of Business Administration from the University of Chicago Booth School of Business. The Company believes that Ms. Burnell is well qualified to serve as a member of the Board due to her expertise and experience in finance, operational oversight, and strategy. Ms. Burnell is the director designated by Pure Crown (as defined below) pursuant to the letter agreement described under “Director Nominations—Agreements to Nominate Certain Directors.”

Daniel Coombs, 67, joined the Board in 2022 and currently serves as Executive Chairman. Prior to joining PureCycle’s Board, Mr. Coombs most recently served from January 2017 through July 2020 as executive vice president global manufacturing, projects and refining for LyondellBasell Industries N.V., a multinational chemical company and licensor of polyethylene and polypropylene technologies. Mr. Coombs previously served as executive vice president for LyondellBasell’s global business lines: olefins and polyolefins from January 2016 to January 2017, intermediates and derivatives from May 2015 to January 2016, and technology from May 2015 to September 2018. Mr. Coombs previously spent 37 years at Chevron Phillips Chemical Company, a petrochemical company, and Phillips Petroleum, a petroleum company, serving as senior vice president global manufacturing from December 2013 to May 2015, specialties, aromatics and styrenics from January 2012 to November 2013, and deputy general manager, Qatar Chemical Company, a chemical and plastics company from 2010 through 2011. Mr. Coombs earned his Bachelor of Science in Chemical Engineering from The Ohio State University, a Master of Science from the University of Tulsa and a Master of Business Administration from Texas A&M University. Mr. Coombs is an American Institute of Chemical Engineers Foundation Trustee and Chairman for the Corporate Council. In addition, Mr. Coombs is a registered professional engineer. The Company believes that Mr. Coombs is well qualified to serve as a member of the Board due to his broad experience in the chemicals and plastics industries. Mr. Coombs became Executive Chairman in August and is one of two directors designated by Sylebra Capital (as defined below) pursuant to the Board Representation Agreement (as defined below) described under “Director Nominations—Agreements to Nominate Certain Directors.”

Jeffrey Fieler, 54, joined the Board in 2021. From December 1, 2023, through February 18, 2024, Mr. Fieler also served as PCT’s interim Chief Financial Officer (“I-CFO”). Mr. Fieler serves as the Chief Investment Officer and

Portfolio Manager, from June 2021, of Veztemida Capital Management, an asset manager. From June 2010 to March 2018, Mr. Fieler served as the Founder and Portfolio Manager of Sylebra Capital Management, a global investment manager, where he managed an active portfolio in the global technology, media and telecommunications sectors with assets under management in excess of $1.5 billion. From May 2003 until June 2010 Mr. Fieler was at Coatue Management, a global investment manager, where he managed investment research and portfolio positions related to the Internet, Media and Telecom industries. He served as partner of Coatue Management from May 2003 until January 2007 and as a Senior Partner from January 2007 until June 2010. From March 2000 until May 2003, Mr. Fieler was a Managing Director and Senior Internet Analyst at Bear Stearns, an investment bank. Mr. Fieler has a Masters in Business Administration from the New York University Stern School of Business and a B.A. from Brown University. The Company believes that Mr. Fieler is well qualified to serve as a member of the Board due to his broad experience in finance and investing. Mr. Fieler is one of two directors designated by Sylebra Capital pursuant to the Board Representation Agreement described under “Director Nominations—Agreements to Nominate Certain Directors.”

Allen Jacoby, 57, joined the Board in 2022. He is an independent director, Chair of the N&CG Committee, and the Lead Independent Director (“LID”) since May 2022. Mr. Jacoby serves as the Chief Strategy Officer and Senior Vice President of Corporate Development for Milliken and Company (“Milliken”), an American industrial manufacturer, since June 2021, and since 2022 also serves as Head of Innovation. Prior to this role, he was the Senior Vice President of the Plastics Additives business at Milliken, from May 2013 to June 2021, and the Business Manager of Industrial Textiles, from September 2009 to May 2013. Mr. Jacoby has served on the boards of the Plastics Industry Association and The Alliance to End Plastic Waste. Mr. Jacoby has a bachelor’s degree in Chemical Engineering from Purdue University and a Masters of Business Administration from The Wharton Business School, with dual majors in finance and entrepreneurial management. The Company believes that Mr. Jacoby is well qualified to serve as a member of the Board due to his more than 30 years of leadership experience in the chemicals and plastics industries in research and development, sales, manufacturing, business leadership, strategy and mergers and acquisitions.

Fernando Musa, 58, joined the Board in 2021. He is an independent director and is a member of the Compensation Committee, Audit and Finance Committee and N&CG Committee. Mr. Musa served as LID from March 2021 until May 2022. Since March 2020, Mr. Musa has served as an Operating Partner of Advent International, a global private equity firm. Since March 2020, he has served as a Senior Advisor of Bain & Company, a global management consultancy firm, and from March to December 2020 was a member of the Advisory Board of Oxiteno, a multinational manufacturer of surfactants and chemicals. Previously, Mr. Musa served as the Global CEO of Braskem S.A., a petrochemical company, from May 2016 to December 2019, as CEO of Braskem America from May 2012 to April 2016, and as Braskem’s Vice President of Planning and Business Development in 2011. In 2010, Mr. Musa was responsible for Braskem’s Quattor Planning and Integration process. Prior to joining Braskem, Mr. Musa was a Partner of Pragma Gestão de Patrimônio Ltda., a wealth management firm, from 2008 to 2009. From 1998 to 2007, Mr. Musa was Managing Partner and Co-Head of the Latin American Practice of Monitor Group, a multinational strategy consulting practice. From 1997 to 2001, Mr. Musa served as Founding Partner of MGDK, a local consulting firm focused on turnaround and venture capital. In 1995 and 1996, Mr. Musa was a Strategic Planning Director at Editora Abril, a publishing and printing company, and was a Business Analyst and Engagement Manager at McKinsey, a worldwide management consulting firm, from 1990 to 1995. Mr. Musa also participated in the Management Trainee Program at The Dow Chemical Company in 1989. Mr. Musa received a degree in Mechanical Engineering from the Instituto Tecnológico da Aeronáutica in 1988, and also received a Masters in Business Administration from Insead in 1992. The Company believes that Mr. Musa is well qualified to serve as a member of the Board due to his vast experience in chemical sciences and his over 30 years of experience in strategic management and finance in leadership roles.

Dustin Olson, 47, serves as the Company’s Chief Executive Officer (“CEO”) since August 9, 2022. Prior to his appointment to CEO, Mr. Olson served as PCT’s Chief Operating Officer, from March 9, 2022, to August 9, 2022, and Chief Manufacturing Officer from January 2021. Previously, Mr. Olson served as the Vice President

of Advanced Polymer Solutions of LyondellBasell, a multinational chemical company and licensor of polyethylene and polypropylene technologies, from August 2018 to December 2020, where he had commercial responsibilities for all advanced polymer solution activities across Asia-Pacific, Africa, the Middle East and India. From June 2017 to August 2018, Mr. Olson served as LyondellBasell’s Director of Polypropylene Compounds, where he was commercially and functionally responsible for polypropylene compounds activities across Asia-Pacific, Africa, the Middle East and India. In addition, Mr. Olson also served as Director of Manufacturing for Compounding, Catalyst and Ethanol for LyondellBasell from June 2015 to June 2017, where he was responsible for all compounding, catalyst and ethanol manufacturing activities across the Americas. Mr. Olson received a B.S. in Chemical Engineering from the University of Missouri-Rolla, a Masters in Chemical Engineering from the University of Houston, and a Masters in Business Administration from Rice University’s Jesse H. Jones Graduate School of Management. The Company believes that Mr. Olson is well qualified to serve as a member of the Board due to his vast experience in the chemicals and plastics industries business leadership and strategy.

Current Executive Officers

Dustin Olson, for Mr. Olson’s biographical information, is immediately above in the Director Nominee and Qualification section.

Brad Kalter, 57, serves as the Company’s General Counsel and Corporate Secretary, from January 2021. Previously, Mr. Kalter served as General Counsel, Chief Legal Officer and Secretary of United Insurance Holdings Corp., a property and casualty insurance holding company, from February 2019 to January 2021. From October 2015 to February 2019, Mr. Kalter served as Executive Vice President, General Counsel and Corporate Secretary of Exide Technologies (“Exide”), a battery manufacturing and energy storage business, overseeing global legal from 2015 to February 2019. Mr. Kalter was responsible for overseeing the legal functions of the organization including corporate governance, compliance, litigation and subsidiary management, as well as overseeing legal aspects of corporate financing transactions and mergers and acquisitions. Mr. Kalter previously served as Vice President, Deputy General Counsel and Corporate Secretary at Exide from 2009 to September 2015 and also as Exide’s Deputy General Counsel and Corporate Secretary, from 2006 to 2008. Prior to joining Exide, Mr. Kalter served as General Counsel at Cotton States Insurance Group, a multi-line insurance group, from 1999 through 2003. Mr. Kalter holds a J.D. from Emory University and a B.A. in Political Science and Communications from the University of Pennsylvania.

Jaime Vasquez, 61 serves as the Company’s Chief Financial Officer, from February 19, 2024. Previously, Mr. Vasquez served as Chief Financial Officer at C&D Technologies, a manufacturer of batteries for the golf cart, industrial, and data center markets, from September 2020 through November 2022. From April 2020 until September 2020, Mr. Vasquez was a financial consultant to C&D Technologies. From 2014 through 2019, Mr. Vasquez was employed at AK Steel, a previously publicly traded steel making company, and served as Chief Financial Officer from 2015 through 2019, and previously as Director of Finance from 2014 through 2015. From 2001 through 2014, Mr. Vasquez worked in various financial roles at Carpenter Technology Corporation, a publicly traded company that develops, manufactures and distributes stainless steels and corrosion-resistant alloys, including as a Division Chief Financial Officer from 2013 through 2014. Mr. Vasquez has a Masters in Business Administration from the University of North Carolina—Bryan School of Business and a Bachelor of Arts from Rutgers University.

Director Compensation

Our director compensation, as recommended by the Compensation Committee and approved by the Board, is intended to attract, retain, and reward Board members who are not employees of the Company. In consideration of the individual time commitments and the goal of aligning compensation with our shareholders’ long-term returns, our non-employee directors receive a combination of equity-based compensation in the form of restricted stock units (“RSUs”), and cash compensation.

The Compensation Committee approved the following change to the director compensation program, effective May 8, 2023: an increase in the annual equity retainer from $110,000 to $125,000. In accordance with the above, non-employee directors received an annual grant of RSUs on May 10, 2023, with a targeted value of $125,000. For purposes of the 2023 RSU grants, the number of RSUs was calculated using the average of the closing price of the Company’s common stock as reported on the Nasdaq Exchange for the twenty consecutive trading days prior to the May 10, 2023, grant date. The RSUs generally vest on the earlier of one year following the grant date or the regular annual meeting of shareholders which occurs in the calendar year following the calendar year in which the grant occurs.

The base cash retainer is $75,000 and was not increased in 2023. Non-employee directors also receive cash compensation for service on committees and as lead director. The annual cash compensation for the Board members is set forth below:


Annual Fee

Base Cash Retainer	$	75,000

Lead Independent Director	$	35,000

Audit and Finance Committee Chair	$	30,000

Compensation Committee Chair	$	20,000

Nominating and Corporate Governance Committee Chair	$	15,000

Non-Chair Audit and Finance Committee Members	$	15,000

Non-Chair Compensation Committee Members	$	10,000

Non-Chair Nominating & Corporate Governance Committee Members	$	7,500

We do not provide any tax gross-ups to our non-executive directors, all of whom are solely responsible for their respective tax obligations as a result of their equity and cash compensation for Board service. Non-employee directors and the Executive Chairman are reimbursed for reasonable expenses incurred in connection with their activities as directors, including attendance at director-education seminars and conferences. Directors who also serve as executive employees do not receive any compensation for their service on the Board.

The following table sets forth the total compensation received by our directors in 2023. Information regarding compensation paid to our directors who are also named executive officers, including Mr. Olson and Mr. Fieler, is not included in the table below and is instead set forth in the 2023 Summary Compensation Table.

2023 Director Compensation


Name	Fees Earned or Paid in Cash⁽¹⁾($)		Stock Awards⁽²⁾ ($)		All Other Compensation ($)		Total ($)

Steven Bouck		95,000		148,620				243,620

Tanya Burnell		115,000		148,620				263,620

Dan Coombs⁽³⁾				107,802		668,349		776,151

Timothy Glockner⁽⁴⁾		28,125						28,125

Allen Jacoby		117,500		148,620				266,120

Fernando Musa		100,000		148,620				248,620

Dr. John Scott⁽⁵⁾		34,375						34,375

(1)	Fees were paid in calendar year 2023 including cash retainer and relevant committee fees.

(2)

Reflects the grant date fair value of 2023 RSU awards, calculated in accordance with Financial Accounting Standards Board Accounting Standards Codification (“FASB ASC”) Topic 718. For information regarding assumptions used in calculating these values, see Note 5 to the Consolidated Financial Statements included in our Annual Report on Form 10-K. As of December 31, 2023, the following outstanding equity awards were held by the non-employee directors: 20,193 RSUs for each of the current non-employee directors set forth above; and 9,827 RSUs for Mr. Coombs (which RSUs were awarded for his service as Executive Chairman as further described in footnote (3) below).

(3)

Mr. Coombs was appointed to our Board on June 1, 2022, as an independent director. Effective August 5, 2022, Mr. Coombs agreed to serve as the Company’s Executive Chairman for a one-year term running through August 4, 2023, which was renewed effective August 5, 2023, and is being paid compensation for such service in lieu of further director compensation during the remainder of such term. During his service as Executive Chairman, Mr. Coombs receives a base salary at an annual rate of $450,000. Mr. Coombs had an opportunity to earn a discretionary cash bonus of up to $225,000 at the end of his initial one-year term as Executive Chairman based on the Board’s subjective evaluation of the success of Mr. Coombs’ oversight activities, and the Board determined that he would receive the full cash bonus of$225,000 for his service through August 4, 2023. Mr. Coombs is not eligible for a cash bonus for his service for the one-year period beginning August 5, 2023. In addition, Mr. Coombs was granted an award of RSUs with a target value of $108,000 (9,827 RSU shares with a grant date fair value of $107,802), which RSUs will generally vest on August 4, 2024, subject to Mr. Coombs’ continued service with the Company through the vesting date. Mr. Coombs anticipates transitioning to a “non-employee” director status in 2024. The amounts reported in the “All Other Compensation” column of this table reflect cash amounts received in his role as Executive Chairman.

(4)	Mr. Glockner resigned from the Board effective as of the date of our 2023 annual meeting of shareholders, May 10, 2023. The amounts listed are for his service prior to his resignation.

(5)	Dr. Scott resigned from the Board effective May 12, 2023. The amounts listed are for his service prior to his resignation.

Director Stock Ownership Guidelines

We maintain stock ownership guidelines that enable us to meet our compensation objective of aligning the interests of our non-employee directors, with those of our shareholders. The stock ownership guideline for our non-employee directors is 3x their annual base cash retainer amount. Non-employee directors are expected to meet the applicable guideline within five years following their appointment or election as a director. As of December 31, 2023, each of our non-employee directors was either in compliance with the stock ownership guideline or was expected to meet such guideline within the applicable five-year period. Because Mr. Coombs is expected to resume his “non-employee” director status in 2024, his stock ownership expectations are measured consistent with our other non-employee directors.

CORPORATE GOVERNANCE

Governance Overview

Our governance framework is designed to be a flexible structure for principled and effective decision-making and compliance with SEC and The Nasdaq Stock Market LLC (“Nasdaq”) requirements. Our Board is committed to developing and continually reviewing our governance framework for alignment with best practices and stakeholder interests and acts to enhance our ability to oversee the execution of strategies that drive value for the Company, our customers, employees and shareholders. PureCycle’s key governance documents, including our Board committee charters and Code of Business Conduct and Ethics, are available on our website at https://ir.purecycle.com/corporate-governance/governance-documents. Information contained on or accessible through our website is not a part of this Proxy and included for reference only.

Code of Business Conduct and Ethics

We have adopted a Code of Business Conduct and Ethics (“Code of Conduct”) applicable to our directors, officers and employees, including our CEO, Chief Financial Officer and other executive and senior financial officers. The Code of Conduct is available on our website at https://ir.purecycle.com/corporate-governance/governance-documents. Our Board is responsible for overseeing the Code of Conduct and must approve any amendments, waivers and exceptions to the Code of Conduct for executive officers and directors. Our Chief Financial Officer and General Counsel must approve any amendments, waivers and exceptions to the Code of Conduct for our employees. We intend to disclose future amendments to the Code of Conduct, or waivers of certain provisions as they relate to our directors and executive officers at the same location on our website to the extent required by applicable rules and exchange requirements. The information on our website is not intended to form a part of or be incorporated by reference into this Proxy Statement.

Anti-Hedging Policy

The Company’s Insider Trading Policy, applicable to all of our officers, directors and employees, and certain third party contractors, imposes prohibitions on (i) short sales of the Company’s securities, (ii) put options, call options or other derivative securities, (iii) entering into other hedging transactions, (iv) pledging, hypothecating or otherwise using Company securities as collateral for a loan or other form of indebtedness, including, without limitation, holding Company securities in a margin account as collateral for a margin loan. Parties subject to the Company’s Insider Trading Policy are also prohibited from engaging in hedging transactions relating to our stock. Additionally, spouses, minor children and any other family member sharing the same household as the directors, officers and employees are similarly prohibited from engaging in such hedging transactions.

Compensation Clawback and Recoupment Policies

In March 2021, the Board adopted a Compensation Clawback and Recoupment Policy pursuant to which we may recover certain incentive payments granted to or received by current or former corporate officers in the event an accounting restatement is required and the Board determines that the current or former corporate officers willfully contributed to the event requiring the accounting restatement. On July 26, 2023, the Board adopted a separate Compensation Clawback Policy (“Section 16 Clawback Policy”) to comply with the mandatory compensation “clawback” requirements under Nasdaq Rule 5608. Under the Section 16 Clawback Policy, in the event of certain accounting restatements, we will generally be required to recover from current or former Section 16 officers any incentive-based compensation representing the excess of the amount actually received over the amount that would have been received had the financial statements been correct in the first instance (without regard to any taxes paid). The Section 16 Clawback Policy is a “no fault” policy and does not require any misconduct on the part of a Section 16 officer or any of his or her subordinates in the case of a restatement. If there is a restatement and the Section 16 officer would have received less incentive compensation under the restated numbers than they actually received, we must seek recoupment of the excess compensation received on or after October 2, 2023, and within the applicable recovery period (which is generally the last three fiscal years)

unless one of the limited exceptions set forth in the Section 16 Clawback Policy applies. “Incentive compensation” includes any compensation that is granted, earned, or vested based wholly or in part upon the attainment of a financial reporting measure.

Communications with the Board

Interested parties may communicate with the Company by letter addressed to Investor Relations, PureCycle Technologies, Inc., 5950 Hazeltine National Drive, Suite 300, Orlando, Florida 32822, or by e-mail to Investor Relations at investorrelations@purecycle.com.

The Company implemented a Shareholder Communications Policy (“Communications Policy”) governing communications between shareholders and the Board. Under the Communications Policy, the Company’s Corporate Secretary has the general responsibility for receiving and reviewing communications addressed to the Board, however shareholders may address communications to the N&CG chair for any communication intended specifically for non-employee directors. Interested parties may communicate with our Board by mailing any inquires to the Board c/o the Corporate Secretary at PureCycle Technologies, Inc., Attn: Brad S. Kalter, 5950 Hazeltine National Drive, Suite 300, Orlando, Florida 32822 or by email at the following address: corporatesecretary@purecycle.com.

Board Independence

Our Board evaluated and affirmatively determined the independence of each of Ms. Burnell and Messrs. Bouck, Jacoby, and Musa: (i) based on each nominee’s completed questionnaire designed to solicit information about relationships that could have an impact on independence and (ii) using standards required by the SEC and Nasdaq. In making these determinations, the Board considered the current and prior relationships that each non-employee director has with PureCycle and all other facts and circumstances the Board deemed relevant in determining a director nominee’s independence, including the beneficial ownership of our capital stock by each non-employee director, and the transactions involving them described below, including the agreement between Mr. Jacoby’s employer and PCT as described below. See “Certain Relationships and Related Party Transactions—Milliken Agreement.” Mr. Fieler was also an independent director prior to his appointment as I-CFO in December 2023, but was not independent while serving in his role as I-CFO.

Each member of our three standing committees is independent under applicable SEC and Nasdaq rules.

Leadership Structure

Our Board regularly reviews the Board’s leadership structure and the standing committees’ responsibilities and composition. The structure and composition of PureCycle’s Board and its committees are intended to leverage the diverse perspectives of the Board members and promote effective oversight. Our Board leadership structure is currently composed of an Executive Chairman (“Chairman”), a Lead Independent Director (“LID”), an independent Audit and Finance, N&CG and Compensation Committee Chair and the CEO.

Mr. Coombs serves as the Board’s Chairman. The Chairman’s activities include, but are not limited to, the following:

•

Serves as a liaison between the Board and CEO.

•

Serves in a strategic and leadership capacity and provides CEO oversight and support in PureCycle’s ramp up in UPR resin production.

Mr. Jacoby currently serves as the Board’s LID. The LID’s activities include, but are not limited to, the following:

•

Develop, in collaboration with the Chairman and CEO, an annual set of topics to be addressed in Board agendas with a focus on the areas of board responsibility.

•

Review and consult with the Chairman on the quality, quantity and timeliness of information sent to the Board.

•

Preside over executive sessions of independent Board members.

•

Lead the Board’s evaluation of the CEO.

•

Call meetings of the independent members of the Board.

•

Communicate feedback to the Chairman from sessions of the independent directors.

•

Provide advice and counsel to the Chairman and other senior management, where appropriate.

•

Maintain availability for communications with major shareholders and other stakeholders, as appropriate.

•

Consult with the Chairman on the retention of outside consultants retained specifically for the Board and authorize the retention of consultants when engagement for directors at the exclusion of the Chairman is deemed appropriate in the LID’s judgment.

•

Coordinate with the Chairman on development of crisis management procedures.

•

Serve as interim chairman in the event of an unforeseen vacancy in the Board Chairmanship.

Our Board believes separating the roles of Chairman and CEO combined with having an LID is in PCT’s and our shareholders’ best interests. The leadership structure with the division of responsibilities listed above supports the Board’s risk oversight efforts because it enables the Chairman to support both the Board and the CEO with balancing long-term strategic development and operations planning and implementation as PCT continues to expand as we begin commercial UPR resin production.

Board Role in Risk Oversight

The Company’s management team is responsible for identifying, evaluating, managing and mitigating the Company’s exposure to risk. Our management team is comprised of our CEO, CFO, General Counsel, Executive Vice President—Manufacturing, Controller, and Chief Sustainability Officer. It is the Board’s responsibility to oversee the Company’s risk management process and to ensure that management is taking appropriate action to identify, manage and mitigate key risks. The Board administers its risk oversight responsibilities through active review and discussion of key risks facing the Company and by delegating certain risk oversight responsibilities to committees for further consideration and evaluation. For more information on each committee’s role in risk oversight, please see below.

Board Committees and Meetings

The current membership and function of each standing committee is described below. Each committee operates under a written charter adopted by the Board and reviewed annually. Committee charters are available on our website at https://ir.purecycle.com/corporate-governance/governance-documents. Each committee meets, and will continue to meet, the composition requirements set forth pursuant to Nasdaq’s rules.

Bouck

Burnell

Coombs*

Fieler*

Jacoby

Musa

Olson*

Audit & Finance

Compensation

Nominating & Corporate Governance

All standing committee members are independent

*	Not independent


Audit and Finance Committee

Chair	Tanya Burnell

Member(s):	Steve Bouck	Fernando Musa

Meetings Held in 2023:	20

Audit and Finance Committee Responsibilities:

•

appoint, evaluate and approve the compensation of our independent registered public accountants;

•

review and approve with our independent registered public accountants the scope and results of the audit engagement;

•

review the independence and qualifications of our independent registered public accountants;

•

pre-approve audit and permissible non-audit services provided by our independent registered public accountants;

•

review our financial statements with management and our independent registered public accountants;

•

review the adequacy of our internal accounting controls, legal and regulatory compliance and risk assessment and risk management, including with respect to cybersecurity, data privacy, data security and continuity;

•

review and approve related-party transactions in accordance with our Related Party Transaction

•

Policy and Procedures as described below;

•

oversee our regulatory and legal compliance;

•

oversee our Code of Business Conduct and Ethics Policy;

•

review any significant financial exposures and contingent liabilities of the Company, including inflation risk, commodity market risk and raw material price risk and the methods used to hedge those exposures;

•

review the Company’s financial outlook and plans for financing its working and long-term capital requirements, including minimum cash requirements and liquidity targets and the Company’s capital plan (capital allocation, funding, and capital expenditures);

•

review strategies and plans for significant transactions, including discussion of possible transactions and their financial impact and various reports on pending and completed transactions; and

•

review and discuss with management any significant cybersecurity incidents, to the extent any occur.

The Board has determined that all members of the Audit and Finance Committee meet heightened independence and qualification criteria as well as meet the financial literacy requirements in accordance with Nasdaq listing standards and SEC rules. The Board has determined that each Audit and Finance Committee member qualifies as an “audit committee financial expert” as defined under SEC rules. See below, “Audit and Finance Committee Report”.


Compensation Committee

Chair:	Steven F. Bouck

Member(s):	Tanya Burnell	Fernando Musa

Meetings Held in 2023:	12

Compensation Committee Responsibilities:

•

oversee compensation risk, structure and philosophy;

•

approve and evaluate executive officer compensation plans, policies and programs;

•

review and recommend director compensation;

•

review and approve compensation for our executive officers other than the CEO, and recommend to the Board the compensation for the CEO;

•

administer employee benefit programs;

•

oversee our human capital management strategy, including diversity and inclusion initiatives; and

•

oversee our executive and director stock ownership policy.

The Board has determined that all members of the Compensation Committee meet heightened independence and qualification criteria in accordance with Nasdaq listing standards and SEC rules. The Compensation Committee’s charter permits it to retain independent advisors, delegate authority to a subcommittee, and delegate to management authority to approve awards or grants under our equity incentive plan. See CD&A section below for more information.


Nominating & Corporate Governance Committee

Chair:		Allen Jacoby

Member(s):		Fernando Musa

Meetings Held in 2023:		4

Nominating & Corporate Governance Committee Responsibilities:

•

review Board structure and composition, consider potential director nominees recommended by other Board members and individual shareholders, and recommend director candidates based on identified criteria;

•

recommend, as needed, a Lead Independent Director;

•

review Board and committee self-evaluation process and meeting procedures;

•

review corporate governance framework, including risks relating to governance policies and procedures;

•

administer employee benefit programs;

•

oversee and review with management shareholder engagement; and

•

support Board’s oversight of company’s sustainability, environment, social and governance program.

The Board has determined that all members of the N&CG Committee are independent in accordance with Nasdaq listing standards and SEC rules. The N&CG Committee’s charter permits the N&CG to retain independent advisors, investigate matters within its scope of authority, and delegate authority to a subcommittee.

Director Meeting Attendance

The Board encourages all directors to attend each meeting of the Board but has not implemented any policies or procedures to mandate attendance. In 2023, the Board met 31 times, and all current directors attended at least 75% of the Board meetings. All committee members attended all meetings of the committees on which they served with the following exceptions: Mr. Fieler was recused from attending three Audit and Finance Committee meetings that addressed a transaction involving Sylebra Capital, a related party; Mr. Bouck and Ms. Burnell were

each unable to attend one meeting of the Compensation Committee due to scheduling conflicts. All Board members serving at the time of the 2023 annual meeting of shareholders attended the 2023 annual meeting of shareholders.

Executive Sessions

The independent members of the Board met in seven executive sessions, which were presided over by the LID.

Board Composition and Refreshment

Board Diversity

Our Board members embody age, gender, and professional diversity. With directors from the chemicals, environmental, finance, and waste management industries, and with leadership experience in technology development marketing, environment and brand building—the Board’s professional experience represents a diversity of perspectives essential to PCT’s successful commercial scaling launch and on-going effective risk oversight.

The demographic information presented below is based on voluntary self-identification by each nominee. Each of the categories listed in the table has the meaning ascribed to it in Nasdaq Listing Rule 5605(f). PureCycle has one director identifying as female and a second director identifying as a member of an underrepresented community, meeting Nasdaq’s diverse director listing requirements.

Diversity Matrix

Diversity Matrix (as of March 28, 2024)*

Total Number of Directors

Gender Identity

Female

Male

Non-Binary

Did Not Disclose
Gender

Directors

Number of Directors–who identify in any of the categories below

African American or Black

Alaskan Native or Native American

Asian

Hispanic or Latinx

Native Hawaiian or Pacific Islander

White

Two or More Races or Ethnicities

LGBTQ+

Did Not Disclose Demographic Background

*	The above matrix presents information about each director on the Board as of the Annual Meeting.

Director Nominations

The N&CG Committee is responsible for identifying and reviewing the qualifications of potential director candidates and recommending qualified director candidates to the Board for possible nomination. The N&CG Committee recommends directors who have the professional experience, qualifications, skills and attributes to guide the Company and function effectively. The N&CG Committee believes that gender, racial and ethnic

diversity on the Board is important and considers those factors in connection with the continuing composition of the Board and any new director-nominees. The N&CG Committee is also responsible for making recommendations to the Board of the criteria to be used by the N&CG Committee in seeking nominees for election to the Board.

Agreements to Nominate Certain Directors

Pursuant to a letter agreement entered between Pure Crown LLC (“Pure Crown”) and PCT, dated October 5, 2020, Pure Crown is entitled to select one director to the Board (the “Pure Crown Director”), and Pure Crown has designated Ms. Burnell as the Pure Crown Director. For so long as Pure Crown has this right to select one director to the Board, any vacancy with respect to the Pure Crown Director may only be filled by Pure Crown.

Furthermore, pursuant to a board representation agreement, dated March 7, 2022, by and between the Company and Sylebra Capital Management (“Sylebra Capital”) in connection with the 2022 Private Investment in a Public Entity (“PIPE”) transaction, Sylebra Capital has been granted the right to designate: (i) one person to be nominated for election to the Board so long as Sylebra Capital together with its affiliates beneficially owns at least 10.0% of the Company’s common stock, and (ii) two persons to be nominated for election to the Board so long as Sylebra Capital together with its affiliates beneficially owns at least 15.0% of the Company’s common stock, subject to certain exceptions, including that Sylebra Capital together with its affiliates will not be entitled to designate more than two nominees. Accordingly, Sylebra Capital is currently entitled to designate two directors for nomination, and has designated Mr. Fieler and Mr. Coombs to serve on the board of PCT.

Shareholder Nominations & Filling Vacancies

Following the vote of shareholders during our 2023 annual meeting, PureCycle’s Amended and Restated Certificate of Incorporation was amended, declassifying the Company’s Board and providing for directors to be elected at each annual meeting of the shareholders. Subject to: (i) the rights, if any, of the holders of any future series of preferred stock to elect additional directors under circumstances specified in a Preferred Stock Designation and (ii) the agreements referenced above in “Agreements to Nominate Certain Directors,” newly created directorships resulting from any increase in the number of directors and any vacancies on the Board resulting from death, disability, resignation, disqualification, removal, or other cause will be filled solely by the affirmative vote of a majority of the remaining directors then in office, even though less than a quorum of the Board, or by a sole remaining director. Any director elected in accordance with the preceding sentence will hold office until the next annual meeting of shareholders and until such director’s successor is duly elected and qualified or until his or her earlier death, disability, resignation, disqualification or removal. No decrease in the number of directors constituting the Board may shorten the term of any incumbent director. Subject to the exceptions and requirements noted above and the procedures set forth in the Company’s Bylaws, directors may be removed by the shareholders at any time, with or without cause.

Board Orientation and Continuing Education

The N&CG Committee leads the Board orientation and onboarding program for new directors. Onboarding includes helping new directors to be integrated into the Board, understand details of PCT’s strategy and receive the information needed to guide our growth and expansion—including the policies and procedures applicable to Board members. Additionally, the N&CG Committee provides the Board, including new directors, with the opportunity to engage with PCT’s management and senior leadership team.

The Board encourages PCT’s directors to pursue continuing education programs focused on PCT’s business and their roles and responsibilities as public company directors. We reimburse PCT’s directors for the costs of these programs. As of December 31, 2023, Mr. Fieler holds a National Association of Corporate Directors’ Directorship Certification.

Board and Committee Evaluations

The Board and each of the Audit and Finance, Compensation and N&CG Committees conduct an annual self-evaluation, which includes both a qualitative and quantitative assessment by each director of the performance of the Board and the committee or committees on which the director sits. The N&CG Committee oversees the evaluation process and each committee chair reports the results to the committees and to the full Board following the end of each year. The Executive Chairman reports the results of the Board evaluations during an executive session of the Board.

Related Party Policy and Transactions

The Audit and Finance Committee has the primary responsibility for reviewing and approving or disapproving “related party transactions,” which are transactions between the Company and related persons in which the aggregate amount involved exceeds or may be expected to exceed $120,000 and in which a related person has or will have a direct or indirect material interest. The written charter of the Audit and Finance Committee provides that the Audit and Finance Committee will review and approve in advance any related party transaction.

Our Board’s Related Party Transaction Approval Policy requires, among other things, that:

•

The Audit and Finance Committee shall review the material facts of all related person transactions.

•

In reviewing any related person transaction, the Audit and Finance Committee will take into account, among other factors that it deems appropriate, whether the related person transaction is on terms no less favorable to the Company than terms generally available in a transaction with an unaffiliated third-party under the same or similar circumstances and the extent of the related person’s interest in the transaction.

•

In connection with its review of any related person transaction, the Company shall provide the Audit and Finance Committee with all material information regarding such related person transaction, the interest of the related person and any potential disclosure obligations of the Company in connection with such related person transaction.

•

If a related person transaction will be ongoing, the Audit and Finance Committee may establish guidelines for the Company’s management to follow in its ongoing dealings with the related person.

Certain Relationships and Related Party Transactions –

The following is a description of each PCT related party transaction since January 1, 2023. There are no currently proposed transactions in which the Company has been or is to be a participant and:

•

The amount involved exceeded or exceeds $120,000; and

•

any of the Company’s directors, director nominees, executive officers, or holders of more than 5% of the Company’s common stock, or any immediate family member of, or person sharing the household with, any of these individuals, had or will have a direct or indirect material interest.

Sylebra Related Party Transactions

Sylebra Credit Facility

On March 15, 2023, the Company entered into a $150 million revolving credit facility (the “Revolving Credit Facility”) pursuant to a credit agreement (as amended, the “Revolving Credit Agreement”) dated as of March 15, 2023, with PureCycle Technologies Holdings Corp. and PureCycle Technologies, LLC (the “Guarantors”), Sylebra Capital Partners Master Fund, LTD, Sylebra Capital Parc Master Fund, and Sylebra Capital Menlo Master Fund (collectively, the “Lenders”), and Madison Pacific Trust Limited (the “Administrative Agent” and “Security Agent”), which had an original maturity on June 30, 2024, and was subsequently extended. The Revolving Credit Agreement has been amended a number of times since March 15, 2023. The Lenders and their affiliates are greater than 5% beneficial owners of the Company.

To date, we have not drawn any funds from the Revolving Credit Facility, and therefore since entry into the Revolving Credit Facility, the largest aggregate amount of principal outstanding under the Revolving Credit Facility was $0. As of this proxy filing, there was $0 outstanding under the Revolving Credit Facility. Since entry into the Revolving Credit Facility, the Company has paid $0 of principal under the Revolving Credit Facility and has paid $0 in interest under the Revolving Credit Facility.

Amounts outstanding under the Revolving Credit Agreement bear interest at a variable annual rate equal to Term SOFR (as defined in the Revolving Credit Agreement) in effect for such period plus an Applicable Margin (as defined in the Revolving Credit Agreement). The Company is also required to pay, quarterly, a commitment fee (as described in the Revolving Credit Agreement) to the Lenders.

Sylebra - The Pure Plastic Term Loan Facility

On May 8, 2023, the Company entered into a $40.0 million term loan facility (the “Term Loan Facility”) pursuant to the term loan credit agreement (as amended, the “Term Loan Credit Agreement”) dated as of May 8, 2023, among the Guarantors and Pure Plastic LLC (as Lender, Administrative Agent, and Security Agent), which matures on December 31, 2025. The Term Loan Credit Agreement has been amended a number of times since May 8, 2023. Affiliates of the Lender are greater than 5% beneficial owners of the Company.

Since entry into the Term Loan Facility in 2023, the largest aggregate amount of principal outstanding under the Term Loan Facility was $43.1 million. As of February 29, 2024, there was $44.1 million outstanding under the Term Loan Facility. Since entering into the Term Loan Facility in, 2023, the Company has paid $0 of principal under the Term Loan Facility and has paid in kind the $3.1 million in interest under the Term Loan Facility, which increased the outstanding principal from $40 million to $43.1 million.

The Term Loan Facility is structured as a single-draw, delayed draw term loan. The Lender funded the term loan on May 17, 2023 (the “Funding Date”). Amounts outstanding under the Term Loan Credit Agreement will bear interest at a variable annual rate equal to Term SOFR (as defined in the Term Loan Credit Agreement) in effect for such period plus an applicable margin equal to 7.5%. The Company is also required to pay a monitoring fee equal to $200,000 to the Administrative Agent for the account of the Administrative Agent and the Security Agent on the Funding Date and each anniversary of the Funding Date until maturity of the term loan.

Sylebra - Green Convertible Notes

On August 24, 2023, the Company completed the private offering of $250.0 million total aggregate principal amount of 7.25% Green Convertible Senior Notes due 2030 (the “Convertible Notes”). The Convertible Notes are senior unsecured obligations of the Company. Entities affiliated with Sylebra Capital, a greater than 5% beneficial owner of the Company, purchased $50.0 million aggregate principal amount at maturity of Convertible Notes.

The Convertible Notes are convertible into PCT Common Stock on the terms and subject to the limitations set forth in the indenture, dated August 24, 2023,(the “Convertible Notes Indenture”), by and between the Company and U.S. Bank Trust Company, National Association, as trustee. Additionally, holders of the Convertible Notes have the right to require the Company to repurchase for cash all or any portion of their Convertible Notes on August 15, 2027, on the terms and subject to the limitations set forth in the Convertible Notes Indenture. In addition, if the Company undergoes a fundamental change (as defined in the Convertible Notes Indenture), holders of the Convertible Notes may require the Company to repurchase their Convertible Notes on the terms and subject to the limitations set forth in the Convertible Notes Indenture. The Company may not redeem the Convertible Notes prior to August 20, 2025. The Company may redeem for cash all or any portion of the Convertible Notes (subject to certain exceptions and restrictions specified in the Convertible Notes Indenture), at its option, on or after August 20, 2025, and on or before the 40th scheduled trading day immediately before the maturity date on the terms and subject to the limitations set forth in the Convertible Notes Indenture.

The Convertible Notes will bear interest at a rate of 7.25% per annum on the principal amount at maturity from August 24, 2023, payable semi-annually in arrears on February 15 and August 15 of each year, beginning on February 15, 2024. Since issuance of the Convertible Notes, the largest aggregate amount of principal of Convertible Notes outstanding under the Convertible Notes Indenture was $250.0 million. As of February 29, 2024, there was $250 million outstanding of Convertible Notes. Since January 1, 2023, the Company has paid $0 of principal on the Convertible Notes and has paid $0 in interest on the Convertible Notes.

Sylebra - Dan Gibson Independent Consultant Agreement

On September 28, 2023, the Audit Committee approved the engagement of Dan Gibson, a principal at Sylebra Capital, as an independent contractor to assist with the Company’s negotiations for a waiver and amendment to the Amended Indenture of Trust, dated as of October 1, 2020 between Southern Ohio Port Authority (the “Issuer”) and UMB Bank, N.A., as trustee (“Trustee”) on behalf of the holders of the $249,500,000 bonds used to construct PureCycle’s flagship commercial scale production facility in Ironton, Ohio (the “Ironton Facility”). Sylebra Capital and its affiliates are greater than 5% beneficial owners of PCT. Mr. Gibson was not compensated for his activities but was provided with a broad indemnification for any potential claims arising out of his services.

Milliken Agreements

In June 2023, PureCycle and Milliken & Company, Mr. Jacoby’s employer, executed a five-year offtake agreement for annual volume of up to 1,000,000 pounds of the Company’s ultra-pure recycled (“UPR”) resin from the Augusta Facility, including a 1,500-pound sample from the Ironton Facility. Payment terms of net thirty (30) days. In November 2023, the Company sold 20,450 pounds polypropylene pellets to Milliken. Additionally, in March 2019, Milliken and PureCycle entered into a 10-year exclusive supply agreement (the “Milliken Supply Agreement”) under which Milliken will supply PureCycle with certain additives needed for the Company’s UPR resin production. Pricing is not specified in the Milliken Supply Agreement, but the agreement notes that pricing will be “reasonable,” reflecting industry conditions with initial pricing negotiated in good faith. In 2023 the Company paid Milliken $502,032.19 for additives and, based on current market rates and conditions and PureCycle’s forecasted operations timeline, we currently estimate that the additives needed for 2024 under the Milliken Supply Agreement will cost approximately $2 million however, no payments are owed until Milliken delivers products ordered.

PROPOSAL TWO — RATIFY GRANT THORNTON LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2024

Our Audit and Finance Committee has appointed Grant Thornton LLP (“Grant Thornton”) as our independent registered public accounting firm for the fiscal year ending December 31, 2024, and we are submitting that appointment to our shareholders for ratification on an advisory basis at the meeting. Although shareholder ratification of Grant Thornton’s appointment is not legally required, we are submitting this matter to the shareholders as a matter of good corporate practice. In determining whether to appoint Grant Thornton as our independent registered public accounting firm, the Audit and Finance Committee considered a number of factors, including, among others, the firm’s qualifications, industry expertise, prior performance, control procedures, proposed staffing and the reasonableness of its fees on an absolute basis and as compared with fees paid by comparable companies.

Vote Required

Shareholder ratification of the appointment of Grant Thornton as our independent registered public accounting firm requires the affirmative vote of the holders of a majority of shares present in person or represented by proxy and entitled to vote on the matter (meaning that of the shares present or represented at the meeting and entitled to vote, a majority of them must be voted “for” the proposal for it to be approved).

Abstentions will have the same effect as a vote “against” this Proposal. This Proposal is considered a routine matter on which the broker will have discretionary authority to vote on the Proposal should a beneficial holder not provide voting instructions. Therefore, there will be no broker non-votes with respect to this Proposal. For that reason, if you are a beneficial holder and you wish to vote “for,” “against” or “abstain” from this Proposal, you will have to provide your broker with such an instruction. Otherwise, your broker will vote this Proposal in its discretion.

Board Vote Recommendation: “FOR” the ratification of the appointment of Grant Thornton as our independent registered public accounting firm for the fiscal year ending December 31, 2024.

If shareholders fail to vote on an advisory basis in favor of the appointment, the Audit and Finance Committee will reconsider whether to retain Grant Thornton and may appoint that firm or another without re-submitting the matter to the shareholders. Even if shareholders ratify the appointment, the Audit and Finance Committee may, in its discretion, select a different independent registered public accounting firm at any time during the year if it determines that such a change would be in the Company’s best interests.

The following table sets forth the amount of audit fees, audit-related fees, tax fees, and all other fees billed for services by Grant Thornton for the years ended December 31, 2023, and 2022. All audit and non-audit services provided to the Company by the independent registered public accounting firm are pre-approved by the Audit and Finance Committee, and the Audit and Finance Committee considers the provision of such non-audit services when evaluating the accounting firm’s independence.


	2023		2022

Audit Fees⁽¹⁾	$	832,405	$	789,214

Audit-Related Fees	$	51,000	$	90,000

Tax Fees⁽²⁾		—		—

All Other Fees⁽³⁾	$	12,806		—


Total Fees	$	896,212	$	879,214

(1)

Includes fees for professional services rendered for the audit of the Company’s annual consolidated financial statements, and review of the consolidated financial statements included in the Company’s Quarterly Reports on Form 10-Q, issuances of comfort letters and consents for securities offerings and for other services that only the Company’s independent registered public accounting firm can reasonably provide.

(2)	Includes fees for professional services in connection with tax compliance, planning and advice.

(3)	Includes fees for all services other than those covered above under “Audit Fees,” “Audit-Related Fees,” and “Tax Fees. No such fees existed for the years ended December 31, 2023 and 2022

Grant Thornton has advised us that one or more of its partners will be present at the meeting. We understand that these representatives will be available to respond to appropriate questions and will have an opportunity to make a statement if they desire to do so.

AUDIT AND FINANCE COMMITTEE REPORT

Our Audit and Finance Committee has oversight authority over the Company’s financial reporting function, including our internal controls over financial reporting (“ICFR”) and our external independent audit process. In carrying out its oversight responsibilities, the Audit and Finance Committee:

•

monitors management’s responsibility for fairly presenting our financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) by maintaining accurate and reliable financial information through our ICFR processes;

•

appoints our independent auditor; and

•

regularly communicates with our independent auditor regarding the scope and status of its annual audit of our consolidated financial statements, including our ICFR.

Management has the primary responsibility for the preparation, presentation and integrity of the Company’s financial statements, for establishing and maintaining internal control over financial reporting and for assessing the effectiveness of the Company’s internal control over financial reporting as of the end of each fiscal year. The Company’s independent registered public accounting firm is responsible for planning and carrying out an audit of the Company’s annual financial statements and the Company’s internal control over financial reporting and expressing opinions as to the conformity of the financial statements with generally accepted accounting principles and the effectiveness of internal control over financial reporting, based on its audits.

As part of the Audit and Finance Committee’s oversight of the Company’s financial statements, the Audit and Finance Committee reviews and discusses with management, the financial controls team and the Company’s independent auditor, management’s key initiatives and programs aimed at maintaining and improving ICFR, and the effectiveness of the Company’s internal and disclosure control structure.

The Audit and Finance Committee met 20 times in 2023, which included, whenever appropriate, executive sessions in which the Audit and Finance Committee met separately with Grant Thornton LLP, our independent registered public accounting firm, as well as representatives of management. Four executive sessions were held in 2023. During 2023, in fulfilling its oversight responsibilities, the Audit and Finance Committee reviewed and discussed the audited consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, with management. Also during 2023, the Audit and Finance Committee discussed with Grant Thornton: (i) those matters required to be discussed by the applicable requirements of the SEC and the Public Company Accounting Oversight Board (“PCAOB”), including the quality of the Company’s accounting principles, the reasonableness of significant judgments and the clarity of disclosures in the financial statements; (ii) the written disclosures required by the PCAOB regarding the independent auditor’s communications with audit committees concerning independence; (iii) Grant Thornton’s independence and considered the effects that the provision of non-audit services may have on Grant Thornton’s independence; and (iv) various other matters pertaining to the audit and other matters handled by Grant Thornton.

Among other matters, over the course of the past year, the Audit and Finance Committee also:

•

appointed, compensated, retained, evaluated and oversaw our independent registered public accounting firm;

•

discussed with our independent registered public accounting firm its independence from management

•

reviewed critical audit matters;

•

reviewed with our independent registered public accounting firm the scope and results of its audit;

•

approved all audit and permissible non-audit services to be performed by our independent registered public accounting firm;

•

oversaw the financial reporting process and discussed with management and our independent registered public accounting firm the interim and annual financial statements that we file with the SEC;

•

reviewed and monitored our accounting principles, accounting policies, financial and accounting;

•

monitored our controls and compliance with legal and regulatory requirements; and

•

established procedures for the confidential anonymous submission of concerns regarding questionable accounting, internal controls or auditing matters.

•

reviewed any significant financial exposures and contingent liabilities of the Company, including inflation risk, commodity market risk and raw material price risk and the methods used to hedge those exposures;

•

reviewed the Company’s financial outlook and plans for financing its working and long-term capital requirements, including minimum cash requirements and liquidity targets and the Company’s capital plan (capital allocation, funding, and capital expenditures); and

•

reviewed strategies and plans for significant transactions, including discussion of possible transactions and their financial impact and various reports on pending and completed transactions.

Taking all of these reviews and discussions into account and subject to the limitations on the role and responsibilities of the Audit and Finance Committee referred to in its charter, the undersigned Audit and Finance Committee members recommended that the Board include the Company’s audited consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2023.

The Audit and Finance Committee has established procedures for the receipt and evaluation, on a confidential basis, of any complaints or concerns regarding our accounting, auditing, financial reporting or related matters. To report such matters please send correspondence to auditcommittee@purecycle.com.

Submitted by the Audit and Finance Committee of the Board of Directors

Tanya Burnell, Chair

Steve Bouck

Fernando Musa

PROPOSAL THREE — ADVISORY APPROVAL OF NAMED EXECUTIVE OFFICER COMPENSATION –

Proposal Purpose

Pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (the “Dodd- Frank Act”) and Section 14A of the Exchange Act, the Company is required to submit to shareholders a resolution subject to an advisory vote to approve the compensation of the Company’s named executive officers (“NEOs”). This Proposal, commonly known as “say-on-pay,” gives our shareholders the opportunity to express their views on the design and effectiveness of our executive compensation program.

Proposal Summary

The Board encourages shareholders to carefully review the “Executive Compensation” section of this Proxy Statement, including the “Compensation Discussion and Analysis” and the related compensation tables and other narrative disclosures, for a discussion of the Company’s NEO compensation program.

The Company’s executive compensation program is designed to attract, develop, and retain motivated executives and key employees who possess the appropriate skill sets and leadership expertise to execute on our long-term strategy. The Company also seeks to design executive compensation to align the interests and objectives of its executives with shareholder interests. The Company’s compensation philosophy (see, page 27 below) is supported by a variety of foundational principles, including that the Company believes all team members should be encouraged to “act like owners” by providing annual equity awards to all team members to promote engagement and differentiate the Company from others in the market.

This vote is not intended to address any specific element of compensation, but rather the overall compensation of our NEOs and the compensation philosophy, policies, practices and disclosures described in this proxy statement.

Accordingly, the following resolution is submitted for an advisory shareholder vote at the Annual Meeting:

“RESOLVED, that the shareholders PureCycle Technologies, Inc. APPROVE, on an advisory basis, the compensation of the named executive officers as disclosed in the Company’s proxy statement for the 2024 Annual Meeting of Shareholders pursuant to the compensation disclosure rules of the Securities and Exchange Commission, including the Compensation Discussion and Analysis and the accompanying compensation tables and narrative discussion within the Executive Compensation section of this proxy statement.”

As this is an advisory vote, the result will not be binding on the Company, the Board or the Compensation Committee, although the Board and the Compensation Committee will carefully consider the outcome of the vote when evaluating the Company’s compensation program. The Company currently holds a say-on-pay vote annually, and the next say-on-pay vote is expected to occur at the Company’s 2025 annual meeting of shareholders.

Vote Required

The affirmative vote of the holders of a majority of shares present in person or represented by proxy and entitled to vote on the matter (meaning that of the shares present or represented at the meeting and entitled to vote, a majority of them must be voted “for” the Proposal for it to be approved).

Abstentions will have the same effect as a vote “against” this Proposal. Broker non-votes will have no effect on the vote for this Proposal.

Vote Recommendation: “FOR” the advisory resolution to approve named executive officer compensation.

EXECUTIVE COMPENSATION

Compensation Discussion and Analysis

PureCycle is scaling novel waste polypropylene recycling technology to produce UPR resin which has nearly the same commercial applications as fossil-based virgin resin. Since becoming publicly listed, PCT’s has focused primarily on completing our Ironton Facility, generating revenue from sale of our UPR resin out of our Ironton facility, expanding our operational footprint in the U.S. and globally, and securing sufficient financing for these projects.

To support these corporate priorities, the Compensation Committee set substantive NEO performance goals for fiscal 2023, including operational targets tied to full-scale plant production as well as financial targets that would support global expansion. During fiscal 2023, PCT made significant progress at Ironton despite multiple challenges during plant commissioning and made meaningful progress towards our long-term strategic goals that are focused on expanding production capacity. Ultimately, the Company fell short of some of our objectives for the year, resulting in NEO bonus payouts at 39% of target.

This Compensation Discussion and Analysis describes the Company’s executive compensation program and provides an overview of our executive compensation-related policies, practices and decisions for 2023. Our “Named Executive Officers” or “NEOs,” for fiscal year 2023 are listed below.

Compensation Philosophy

PureCycle’s executive compensation program is designed to attract, develop, and retain motivated executives and key employees who possess the appropriate skill sets and leadership expertise to execute on our long-term strategy. We analyze peer group and survey data to help ensure that our executive compensation program is market-competitive. We also seek to design executive compensation to align the interests and objectives of our executives with shareholder interests through providing annual equity awards to all team members to encourage them to “act like owners” and strategically differentiate ourselves from others in the market.

Our 2023 NEOs were:


Name		Title

Dustin Olson		Chief Executive Officer

Jeffrey Fieler		Former Interim Chief Financial Officer

Lawrence Somma		Former Chief Financial Officer

Brad Kalter		General Counsel and Corporate Secretary

2023 Key Leadership Changes

Effective December 1, 2023, Mr. Somma resigned as the Company’s Chief Financial Officer (“CFO”). In connection with his departure, the Company and Mr. Somma entered into a Separation and Release Agreement (“Separation Agreement”) under which Mr. Somma received a cash payment of $300,000, full accelerated vesting of the remaining unvested RSUs that were part of his original grant upon joining the Company in November 2021, pro-rated vesting of all remaining outstanding awards under the PureCycle Technologies, Inc. 2021 Equity and Incentive Compensation Plan through December 1, 2023, and the right to certain COBRA reimbursements. (For more information about Mr. Somma’s total compensation, please see the Separation Agreements and Compensation Tables sections below).

Interim CFO

Effective December 1, 2023, the Board named Mr. Fieler as PCT’s interim Chief Financial Officer (“I-CFO”). Mr. Fieler served as I-CFO through February 18, 2024, when PCT named our new CFO, Jaime Vasquez. Upon appointment as I-CFO, the Board determined Mr. Fieler was no longer an independent director and he resigned

from his Board committee assignments but continued serving as a non-independent member of the Board. Mr. Fieler’s I-CFO compensation structure reflected the temporary nature of his role during the leadership transition months rather than as an executive compensation package designed to attract and retain his services long term. Consequently, the compensation philosophy and other metrics discussed below, and applicable to NEO compensation design and decisions, were not the basis of Mr. Fieler’s I-CFO compensation design.

Specifically, Mr. Fieler’s compensation for his I-CFO role was based upon Mr. Somma’s compensation value, but was entirely stock based—he did not receive any cash compensation for such service. For the duration of his I-CFO service, he received monthly compensation equal to approximately $42,500 in PCT common stock based on the weighted average closing price of PCT’s common stock for the twenty trading dates including the last day of the month of service. Additionally, following his I-CFO service, and pro-rated based on the number of months served (relative to a consecutive twelve month period), on February 28, 2024, Mr. Fieler received a bonus (as further described below) valued at $90,000 and paid in the form of 18,181 PCT shares, based on the weighted average closing price of PCT’s common stock for the twenty trading days preceding the grant date. As I-CFO, Mr. Fieler was not eligible for an annual long-term incentive (“LTI”) grant or short term cash incentive (“STI”) compensation for 2023 and will not be eligible for 2024. Mr. Fieler continued to receive his cash and equity compensation as a member of the Board during his service as I-CFO.

New CFO

Jaime Vasquez was appointed CFO on February 19, 2024. Mr. Vasquez will receive an annual base salary of $510,000, is eligible to participate in the Company’s 2024 STI plan, with a target payment of seventy percent (70%) of his base salary and participate in the 2024 LTI program, with a grant date value targeted at one hundred and twenty-five percent (125%) of his base salary. Mr. Vasquez’s annual STI and LTI awards will not be pro-rated based on his date of employment. Mr. Vasquez will also receive reimbursement of a maximum of $26,000 to establish a residence in the Orlando, Florida area. Mr. Vasquez will be eligible to participate in the Company’s Executive Severance Plan (the “Severance Plan”). Because Mr. Vasquez started his CFO role in 2024, this proxy does not include other details about his compensation, but we expect to provide his 2024 compensation detail in our 2025 proxy statement.

Pay Practices Supporting Good Governance

Compensation Risk Controls

The Compensation Committee works with management to conduct an annual review of our compensation-related risks. The risk assessment conducted during fiscal year 2023 did not identify any significant compensation-related risks that are not appropriately mitigated as a result of compensation plan design, and concluded that our compensation programs encourage actions aligned with the interests of shareholders. The analysis concluded there was a sufficient balance among fixed versus variable pay, cash and equity, and corporate and individual goals. As a result, we determined that our compensation policies and practices do not create risks that are reasonably likely to have a material adverse effect on PureCycle.

Executive Stock Ownership Guidelines

We maintain stock ownership guidelines that enable us to meet our compensation objective of aligning the interests of our executive officers, including our NEOs, with those of our shareholders. Executive officers are expected to meet the applicable guideline within five years following their hire date, elevation to an executive

position or the Company’s public listing, whichever is later. As of December 31, 2023, each of our continuing NEOs was either in compliance with the stock ownership guideline or was expected to meet such guideline within the applicable five-year period.


Named Executive Officer	Target Stock Ownership as a Multiple of Base Salary		Compliance Status

Dustin Olson, CEO		4X		On Track⁽¹⁾

Lawrence Somma, Former CFO		3X		⁽²⁾

Jeffrey Fieler, I-CFO		N/A		⁽³⁾

Brad Kalter, General Counsel & Secretary		3X		On Track⁽¹⁾

(1)	Based on current and expected annual equity awards, the Company anticipates each of Messrs. Olson and Kalter will meet the minimum holdings requirement within the five-year period.

(2)	Mr. Somma resigned in December 2023; however, the Company expects Mr. Vasquez to meet the same stock ownership requirement.

(3)	Inapplicable to Mr. Fieler. For more information about Mr. Fieler’s compliance with the Stock Ownership Guidelines for directors, see “Key Leadership Changes” above.

No tax gross ups

We have not entered into agreements with our NEOs that provide for tax “gross-ups.”

Incentive awards capped

Compensation under our LTI and STI programs are individually capped at 200% of target. We believe a maximum 2x multiple for incentive compensation, requiring significant performance above target, provides appropriate upside potential while also serving as a key risk mitigator in our plan.

Limited Perquisites.

We believe that perquisites, as a general rule, should not form a material component of executive compensation. In 2022, the Compensation Committee approved enhanced annual physicals for NEOs. The cost of the physical and any required lodging associated with such physical are reimbursed by the Company. There are no other significant executive perquisites.

How We Make Executive Compensation Decisions

Compensation Committee Role

The Compensation Committee is comprised solely of independent directors and operates under a Board-approved charter outlining the Compensation Committee’s primary duties and responsibilities. The charter is available on the Investor Relations page on the PureCycle website. The Compensation Committee discharges certain responsibilities of our Board with respect to NEO compensation, including reviewing our executive compensation programs, recommending compensation levels for our CEO to the Board, and approving compensation for our executive officers other than our CEO. Further, the Compensation Committee is responsible for reviewing, discussing, and approving the Compensation Discussion and Analysis and the accompanying Compensation Committee Report for inclusion in the annual proxy statement that we file with the SEC.

Independent Compensation Consultant

The Compensation Committee engages an external compensation consultant, who reports directly to the Compensation Committee and provides competitive market data, analysis and other resources to assist with our overall executive compensation strategy. In 2023, the Compensation Committee engaged Frederic W. Cook & Co., Inc. (“FW Cook”) as its independent compensation consultant to assist the Compensation Committee with designing executive and director compensation, as well as compensation for our executive officers, consistent with market practices and our selected peer group, including compensation philosophies, strategies, pay levels, decision-making processes, and other matters within the scope of the Compensation Committee’s responsibilities. FW Cook does not perform any other work for us, does not trade our stock, has independence policies that are reviewed annually and will proactively notify the Compensation Committee chair of any potential or perceived conflicts of interest. The Compensation Committee found no conflict of interest during fiscal year 2023 with respect to FW Cook. The Compensation Committee deemed FW Cook independent for 2023.

Chief Executive Officer Role

Our CEO recommends to the Compensation Committee, in the case of other executive officers, base salary amounts, STI awards and LTI awards, as well as potential adjustments to each component of compensation based on individual performance.

Consideration of Results of Say-on-Pay Vote

At our 2023 annual meeting of shareholders, we held our first advisory vote to approve the Company’s named executive officer compensation (commonly referred to as a “say-on-pay” vote). More than 95% of the votes cast in such say-on-pay vote were in support of our 2022 NEO compensation. Following the results of this vote, we continued to apply similar principles to our executive compensation decisions and did not make any changes to our compensation programs for 2023 as a direct result of such vote. At our 2023 annual meeting of shareholders, we also held our first “say-on-pay frequency” vote, pursuant to which shareholders had an opportunity to cast an advisory vote on the frequency of future say-on-pay votes. The majority of our shareholders voted in favor of holding a say-on-pay vote every year. As such, we expect to hold future say-on-pay votes on an annual basis.

Fieler Compensation

As noted above under “2023 Key Leadership Changes,” Mr. Fieler’s I-CFO compensation structure reflected the temporary nature of his role during the leadership transition months rather than an executive compensation package designed to attract and retain his services long term. Consequently, the compensation philosophy and other metrics disclosed and discussed in this Compensation Discussion and Analysis, and in the tables below, were not the basis of Mr. Fieler’s I-CFO compensation design.

Peer Group for Executive Compensation

We used data from a peer group to assist the Compensation Committee in setting each NEO’s compensation, and we generally seek to approximate the median of our peer group (described below) with respect to the total direct compensation (base salary, target STI, and target LTI) of our NEOs. However, given our status as company with limited revenue at this juncture and the need to retain key talent, 2023 LTI awards to our NEOs were generally designed to exceed this level. Further, market data is just one of several factors that we examine in determining compensation levels and we determine design and market levels based on PCT’s status as a newly operating company. Pay for any NEO may be above or below market based on other factors, including an individual NEO’s performance, experience, responsibilities or tenure in a role, any special skills, and market demand.

The initial peer group (which was approved in November 2021 and used for 2022 compensation decisions) was based on various objective and subjective criteria including the following:

•

Competitors for Business—industry competitors; companies subject to similar economic opportunities and challenges;

•

Competitors for Talent—direct and related industry companies in which PureCycle could reasonably compete for executive talent;

•

Scale—companies of similar market cap and the Company’s expected revenue size once operating at scale, but companies may exceed this size range if direct competitors are in a niche industry;

•

Niche Industry—PCT operates in a niche industry where direct competitors include private companies and subsidiaries of large conglomerates. Given the limited number of direct competitors of appropriate scale, inclusion of some companies that operate outside the industry is necessary to provide a statistically relevant sample set; and

•

IPO/SPAC—As a recently post-SPAC business combination public company, PCT is a pre-revenue company, which impacts scaling of potential peer companies. SPACs are often emerging growth companies with limited pay disclosure, which eliminates some of them as potential peers for pay benchmarking purposes at this time.

In 2022, as a result of certain mergers & acquisition (“M&A”) activity and changes in financial size, FW Cook recommended, and the Compensation Committee agreed, to add five new peer companies (Archaea Energy Inc., Danimer Scientific, Inc., Li-Cycle Holdings Corp., Origin Materials, Inc., and Trex Company, Inc.) to replace three companies that have been acquired through M&A activity (Covanta Holding Corporation, Renewable Energy Group, and US Ecology Holdings, Inc.) and two peer companies that are no longer deemed appropriate (ESCO Technologies Inc. and CIRCOR International, Inc.). The range of annual revenues for peer group members was determined so that our expected annual revenue once operating at scale would be comparable to the median of the peer group. This revised peer group was used for compensation decisions for our NEOs for fiscal 2023 and consists of the following companies:


2023 Peer Group

Advansix Inc.	Casella Waste Systems, Inc.	Heritage-Crystal Clean, Inc.	Montrose Environmental Group, Inc.

Amyris, Inc.	Danimer Scientific, Inc.	Li-Cycle Holdings Corp.	Origin Materials, Inc.

Archaea Energy Inc.	Energy Recovery, Inc.	Livent Corporation	Tredegar Corporation

Bloom Energy Corporation	Enviri (f/k/a Harco Corporation)	Loop Industries, Inc.	Trex Company, Inc.

Pay Elements

Overview — What We Pay and Why


Element	Key Characteristics	Purpose	2023 Changes
Base Salary	Fixed amount paid in cash, reviewed annually.	Provides fixed income that is market competitive and reflective of the executive’s role and experience to help attract and retain executive talent.	In 2023, Messrs. Somma and Kalter each received a 2% increase in base salary, below the salary increase provided to other salaried employees. Mr. Olson did not receive any adjustment to his base salary.


Element	Key Characteristics	Purpose	2023 Changes
STI	Variable compensation, generally paid in cash, and subject to pre-established annual financial and operational targets and personal performance.	Incent executives to achieve and exceed annual financial and strategic objectives.	Used new metrics under 2023 STI program to include goals based on liquidity and Ironton viability.

LTI	Variable compensation, with multi-year vesting schedules and a mix of performance stock awards (“PSUs”) (based on achievement of three-year goals), stock options that vest after three years, and restricted stock units (“RSUs”) that vest ratably over four years.	Align interest of executives with shareholders and serve as an appropriate retention tool.	Added non-qualified stock options as a component of annual equity grants as they are more directly aligned with increasing share value. Because stock options are most dilutive and due to their volatility, they are used for members of our executive leadership team that have direct influence on the strategy and performance of the organization at the highest levels. Used new metrics under 2023 LTI program to includes goals based on project growth, advance growth projects and expansion into additional plastics recycling

Benefits	Includes medical, dental, vision, short-term and long-term disability, and certain other benefits.	Competitive health and welfare benefits.	No significant changes.

Perquisites	Designed not to represent a significant part of annual compensation.	Provide certain benefits to our executives designed to ensure ability to meet the rigors associated with an executive position of a publicly listed company.	No significant changes.

Base Salary

General. We set base salaries for new executive officers at the time of hire and review base salaries for our executive officers on an annual basis to help ensure they remain market competitive and consistent with our peer group, and reflect the scope and responsibility of their positions, as well as their prior experiences. Base salaries for 2023 for our NEOs were reviewed and discussed at a regular meeting of the Compensation Committee and were effective April 2, 2023. Base salary for the CEO is recommended by the Compensation Committee and approved by the Board. We also review base salaries upon a meaningful change in an executive officer’s responsibilities or role.

We take into consideration several factors in setting initial base salary or when annually reviewing base salaries for our executive officers, including: current base salary; positioning relative to competitive market data and peer companies; scope of the position; prior professional experience; and internal pay comparisons. The fiscal 2023 base salaries, determined by the Compensation Committee based on its consideration of those factors, and any percent increase over the fiscal 2022 base salaries, are provided in the table below.


NEO	Base Salary Rate as of 2022 Fiscal Year-End			Base Salary Rate as of April 2, 2023⁽¹⁾		Percentage Increase Over Prior Year

Dustin Olson	$	773,000		$	773,000		N/A	⁽²⁾

Jeffrey Fieler		⁽³	⁾		—		—

Lawrence Somma	$	500,000		$	510,000		2	%

Brad Kalter	$	400,000		$	408,000		2	%

(1)	Base salary increases for Messrs. Somma and Kalter were effective as of April 2, 2023.

(2)	Mr. Olson did not receive a base salary adjustment in 2023.

(3)	Inapplicable to Mr. Fieler. However, for his December 2023 I-CFO service, Mr. Fieler received 9,953 shares, valued at $40,310, on January 2, 2024. For more information about Mr. Fieler’s compensation for his I-CFO role, see, 2023 Key Leadership Changes above.

Annual Cash Incentives

STI Overview.

Our annual incentive compensation program is designed to motivate and reward Company employees, including the NEOs, to create long-term value by achieving key short-term business objectives. The inclusive design is intended to align and motivate our entire PCT team to diligently pursue and prioritize achieving our annual performance objectives. We set annual incentive compensation targets for our NEOs starting with a multiple of base salary.

The Compensation Committee annually reviews and determines each NEO’s cash incentive opportunity, the payout of which is based on achievement of pre-established overall Company operational and strategic goals (a Company performance element) and each NEO’s individual impact (an individual performance element). If appropriate, the Compensation Committee may review and adjust performance criteria during the year. Actual NEO cash incentives earned may be more or less than the target amount depending on a combination of company and individual performance. The Compensation Committee evaluates NEO performance based on both an objective analysis and subjective analysis: (a) objective analysis is a fixed formula result which includes reviewing detailed financial models showing variations in compensation at differing levels of achievement and (b) subjective analysis is the Compensation Committee’s assessment of the objective analysis result in context of contributions toward strategic or operational objectives and actual value realized—meaning the Compensation Committee, in its judgement, may exercise discretion, positive or negative, to adjust the total value of incentive compensation in light of financial and non-financial performance. The Compensation Committee believes our STI program structure aligns with strategic priorities and underscores the importance of both financial and non-financial performance and successfully motivates employees, including NEOs, to achieve holistic performance that both promotes PCT’s long-term value opportunities for our shareholders and is reasonable in relation to actual annual performance.

Actual STI payouts with respect to the Company performance element can range from 0% (if threshold levels of performance are not met) to 200% of the target award (if maximum levels of performance are met for all of the performance measures). Actual STI payouts with respect to the individual performance element can range from 0% to 200% of the target award based on the Compensation Committee’s subjective evaluation of each NEO’s performance. When determining the target award for each NEO, the Compensation Committee generally

references the median of our peer group for target total cash compensation (sum of base salary and target annual cash incentive) for the position in which such NEO serves. The annual award for the CEO is recommended by the Compensation Committee and approved by the Board.

2023 Short-Term Cash Incentive Award Targets

The 2023 STI design provided NEOs with an opportunity to earn cash incentive payments based on Company performance goal achievements (weighted at 70%) and individual performance achievement (weighted at 30%), with potential payouts ranging from 0% to 200% of target. The Compensation Committee approved the fiscal 2023 award opportunities for our NEOs under the Company’s STI program as set forth below (which were unchanged, as percentages of base salary, from 2022 award opportunities):


NEO	Target Payout (as a % of Base Salary)			2023 STI Target Award

Dustin Olson		100	%	$	773,000

Jeffrey Fieler⁽¹⁾		N/A			N/A

Lawrence Somma⁽²⁾		70	%	$	355,255

Brad Kalter ⁽²⁾		70	%	$	284,204

(1)	Inapplicable to Mr. Fieler. For more information about Mr. Fieler’s compensation for his I-CFO role, see, 2023 Key Leadership Changes above and the discussion below.

(2)	STI target awards are prorated based on salary adjustments that occurred during 2023 for Mr. Somma and Mr. Kalter.

2023 Short-Term Cash Incentive Award — Performance Criteria.

For the strategic Company performance criteria, representing 70% of each NEO’s weighted STI target, the Compensation Committee established the following performance goals under the 2023 STI program for the NEOs:


	Level of Performance
Performance Metric and Weighting	Threshold (50%) payout	Target (100% payout)	Maximum (200% payout)
Demonstrate Ironton’s Commercial Viability (50%)	Deliver Adjusted EBITDA >$0MM over a consecutive three-month window	Deliver Adjusted EBITDA >$9.42MM over a consecutive three-month window	Deliver Adjusted EBITDA >$11.7MM over a consecutive three-month window

Ensure enough liquidity to be able to meet all commitments for fiscal 2023 (50%)	Raise $100MM capital	Raise $500MM capital	Raise $800MM capital

The Compensation Committee did not implement pre-established individual goals for each NEO’s performance criteria in 2023 and instead planned to evaluate the NEOs based on their overall contributions toward the Company strategic objectives.

2023 Short-Term Cash Incentive Award Payout Determinations

The Company and its employees experienced numerous challenges in 2023. While we realized several key milestones toward commercial scale production of UPR resin, including achieving mechanical completion and intermittent pellet production at the Ironton purification facility, and made progress toward global expansion, the pace of our progress was slower than planned. Consequently, our overall results were negatively impacted by the challenges we faced and our performance payouts were below target.

Strategic Company Performance Review.

The formulaic results with respect to the strategic Company performance goals (which comprised 70% of the 2023 STI program opportunities) are illustrated in the following table.


Performance Metric	Actual Results	Formulaic Payout Percentage for each Metric			Metric Weight			Final Weighted Payout Percentage
Demonstrate Ironton’s Commercial Viability	The Company did not meet the Adjusted EBITDA threshold performance		0	%		50	%		0	%
Ensure enough liquidity to be able to meet all commitments for fiscal 2023	$322 million of capital raised		78	%		50	%		39	%
Total Strategic Company Performance Goals Payout %									39	%

Individual Performance Achievements

The Compensation Committee did not identify pre-established performance goals for the individual performance criteria in 2023. Rather, the Compensation Committee reviewed each of Messrs. Olson’s and Kalter’s individual efforts toward pursuing the Company’s performance goals and contributions to progress made despite challenging circumstances. Both Messrs. Olson and Kalter pursued and supported Company strategic objectives, meeting the Compensation Committee and Board’s individual performance expectations. Although both Messrs. Olson and Kalter contributed to our near and long-term growth opportunities, given our challenging 2023 overall performance, the Compensation Committee concluded that our long-term value would be best served by using its discretion to match Messrs. Olson’s and Kalter’s individual performance results with overall Company performance. Accordingly, the Compensation Committee determined that the payout percentage for the individual performance component of the STI for Messrs. Olson and Kalter would be 39% of target. When combined with the final weighted payout percentage for the strategic Company performance goals of 39%, this resulted in an overall payout percentage under the STI of 39% of target.

In general, 2023 STI program participants must remain continuously employed by the Company until the award payment date in order to receive a payout of an award under the 2023 STI.

The following table indicates the actual STI program payment made to each NEO for fiscal 2023:


NEO	2023 STI Target Award ($)		Total Payout % (as a % of Target)			Actual STI Payout ($)
Dustin Olson		773,000		39	%		301,470
Lawrence Somma⁽¹⁾		355,255		N/A			N/A
Brad Kalter		284,204		39	%		110,839
Jeffrey Fieler⁽²⁾		N/A		N/A			N/A

(1)	Mr. Somma forfeited the right to receive a payout under the 2023 STI due to his resignation effective December 1, 2023.

(2)	Inapplicable to Mr. Fieler. For more information about Mr. Fieler’s compensation for his I-CFO role, see, 2023 Key Leadership Changes above and the discussion below.

As described below, the Company entered into an independent contractor agreement with Mr. Fieler in connection with his appointment as I-CFO. Under the terms of the independent contractor agreement, Mr. Fieler

was eligible for a minimum bonus at the conclusion of his service as I-CFO of $360,000, subject to pro-ration based on the number of months (relative to a full year) during which Mr. Fieler served as I-CFO. The bonus could have been increased up to a total of $720,000 (subject to pro-ration as described above) based on Mr. Fieler’s performance as I-CFO in the discretion of the Compensation Committee. At the conclusion of Mr. Fieler’s service as I-CFO in February 2024, the Compensation Committee determined not to increase his bonus above the $360,000 level, and such amount was pro-rated to be $90,000. In accordance with the terms of the bonus, it was paid in the form of 18,181 PCT shares, based on the weighted average closing price of PCT’s common stock for the twenty consecutive trading days preceding the grant date of the shares. Because the shares were earned and paid in 2024, their value does not appear in the 2023 Summary Compensation Table, but we expect to include the value of such shares in the Summary Compensation Table in our 2025 proxy statement.

Long-Term Incentive Equity Awards

LTI Overview

We believe our LTI program opportunities, along with our stock ownership guidelines, align the interests of our executive officers with the interests of our shareholders. We provide our NEOs an opportunity to earn market and peer group competitive long-term incentives in the form of PSU, stock option and RSU awards. In determining the size of these long-term incentive awards for each NEO, we consider market data, the scope and complexity of the executive’s position, experience, and internal pay comparisons.

Previously, one-half of the long-term incentive value was delivered in the form of RSUs and one-half was delivered in the form of PSUs. For fiscal 2023, the Compensation Committee determined that non-qualified stock options would be added to the awards to our NEOs with the following allocation: PSUs (25%), stock options (25%), and RSUs (50%). These LTI awards were approved by the Compensation Committee (and recommended to the Board by the Compensation Committee for the CEO) at its regular meeting held in the first fiscal quarter of 2023. We believe this allocation of equity awards provides an appropriate balance between rewarding achievement of Company-specific performance measures and delivering long-term incentive value through stock performance. Given the early-stage challenges typical for pre-revenue companies, the Compensation Committee believes above-market target equity awards are appropriate and seeks to set annual LTI award targets above the median of our peer group. As the Company matures, the Compensation Committee expects to adjust annual LTI target awards and provide target values that are closer to the market median.

PSU Awards

PSU awards are paid out in shares of our common stock following completion of a three-year performance period if certain performance goals are achieved as determined by the Compensation Committee. The Compensation Committee establishes performance measures and weighting for the entire three-year performance period, as well as thresholds and maximums. Factors the Compensation Committee considers when establishing the performance goals for the three-year period include our status as a pre-revenue company, as well as near-term and long-term strategic goals. At the end of the three-year performance period, we expect management to present a summary of performance against the performance goals and the Compensation Committee to make a final determination of actual achievement against these goals. Actual payouts can range from 0% (if the threshold performance levels are not met) to 200% of the target award (if maximum performance levels are met).

The PSUs granted in 2023 will be earned based on achievement of three weighted pre-established performance objectives related to: (i) domestic project growth (weighted 50%), (ii) advance international growth projects (weighted 35%), and (iii) expansion into additional plastics recycling (weighted 15%), and will vest on the date the attainment of such performance objectives is determined by the Compensation Committee (or, with respect to the CEO, by the Board), subject to the participant’s continued employment with the Company through December 31, 2025. The actual number of shares (if any) issued in settlement of the PSUs may range from 50% (if threshold performance is achieved) to 200% of target. In general, we do not disclose the specific, forward-looking goals that we established for the 2023 PSUs because (1) these goals relate to executive compensation to

be earned and/or paid in future years and do not affect a fair understanding of the NEOs’ compensation for 2023 and (2) we believe that disclosure of such goals while the applicable performance period is ongoing would cause us competitive harm. However, we expect to disclose such goals in future proxy statements once the applicable performance periods have ended as part of our discussion of the amounts earned by our NEOs under these awards.

Settlement of 2021 — 2023 PSU Award

Due to operational challenges, the Company did not meet 2021-2023 LTI minimum performance threshold objectives. Applicable NEO PSUs were therefore forfeited and returned to the pool of shares eligible for award under the Plan. The table below shows the applicable goals, achievement and actual results with respect to the 2021-2023 PSU awards.

2021-2023 PSU Metric - Goals

Weighting

Threshold
50%

Target
100%

Maximum
200%

Total Production in FY (MM lbs)⁽¹⁾

100

133MM

178MM

222MM


2021-2023 PSU Metric - Achievement	Weighting			FY 2021		FY 2022		FY 2023		2021-2023		Attainment
Total Production in FY (MM lbs)⁽¹⁾		100	%		—		—		97MM		97MM		0	%

1	Goals (threshold, target and maximum) for product produced (includes co-products) are cumulative achievements for across the 3-year plan. Co-Products represent the purification section co-products; Scheibel OH and Settler Bottoms.

Non-qualified Stock Options

In 2023, the Compensation Committee allocated 25% of NEO long term incentive compensation in the form of a non-qualified stock option with a ten-year term, that cliff vests at the end of a three-year period. The Company believes stock options are a good mechanism to link executive compensation to long-term company performance because their value is realized through an increase in the market value of the Company’s common stock, thereby linking that element of compensation to Company performance. In determining the grant date fair values of these option awards we use the Black-Scholes option pricing model with the following assumptions: expected annual dividend yield, expected volatility, risk-free rate of return, expected option term (in years).

Restricted Stock Unit Awards

The Compensation Committee also grants RSUs. RSU awards generally vest in four equal annual installments following the grant date, in each case subject to the participant’s continued employment with the Company through the applicable vesting date. We believe that the RSU awards serve as a retention tool for our executive officers and that the long-term value of such awards aligns our executive officers’ goals with those of our shareholders.

Our NEOs received the following initial long-term incentive award opportunities in 2023:


NEO	Target LTI Value ($)⁽¹⁾		Options (#)		PSUs (#)		RSUs (#)
NEO	Target LTI Value ($)⁽¹⁾		Options (#)		PSUs (#)		RSUs (#)
Dustin Olson		3,000,000		169,300		131,578		263,157
Jeffrey Fieler⁽²⁾		N/A		—		—		—
Lawrence Somma⁽³⁾		1,225,000		69,130		53,728		107,456
Brad Kalter		925,000		52,200		40,570		81,140

(1)

Mr. Somma’s and Mr. Kalter’s 2023 LTI target value is based on a percentage of their initial base salary rates in 2023 as approved by the Compensation Committee: 200% for Mr. Somma and 175% for Mr. Kalter. The Compensation Committee also approved a special increase in the LTI target value (for 2023 only) for each of Mr. Somma and Mr. Kalter equal to $225,000. The increase in such targets compared to 2022, as well as the special increase for 2023 only, were implemented to incentivize retention.

(2)	Inapplicable to Mr. Fieler. For more information about Mr. Fieler’s compensation for his I-CFO role, see, 2023 Key Leadership Changes above and Independent Contractor Agreement below.

(3)	Mr. Somma is eligible for a prorated payout of his 2023 LTI awards based on his termination date December 1, 2023.

2023 Goal Setting

In order to help ensure STI and LTI compensation are aligned with both Company performance and the evolution of corporate strategy, incentive goals and targets are not automatically carried forward year over year. Rather, the Compensation Committee reevaluates performance goals to help ensure goals are: (i) designed to incentivize our executives to drive our key strategic objectives over the relevant performance period; (ii) challenging and sufficiently rigorous; (iii) appropriately reflective of business and market conditions; and (iv) aligned with shareholder interests.

Other Compensation Related Matters

Retirement Benefits

We offer a tax-qualified retirement savings plan to our employees, under which participating employees may contribute a portion of their eligible compensation into their plan accounts. Each of the NEOs was eligible to participate in the plan during fiscal 2023. The Company makes contributions under the 401(k) plan matching the employee’s own contributions dollar for dollar up to 4% of the employee’s contributions, subject to IRS limits.

Offer Letters

We are party to an offer letter with Mr. Olson that was entered into in connection with his initial commencement of employment as our Chief Manufacturing Officer in January 2021. The offer letter provides for the basic terms of Mr. Olson’s employment, including an initial annual base salary rate of $400,000, a target STIP opportunity equal to 20% of base salary, and other customary employee benefits. The offer letter provides that the Company will reimburse Mr. Olson for up to $100,000 in relocation expenses. The offer letter also contemplates an anticipated future equity award, the value of which is expected to be between $1,000,000 and $3,000,000, which is expected to be granted following the commissioning of the Ironton Facility. Mr. Olson’s offer letter was not revised in association with his promotion to Chief Operating Officer on March 9, 2022, or his August 5, 2022, appointment as Chief Executive Officer, although certain elements of his compensation were adjusted in connection with those appointments.

In connection with his commencement of employment in November 2021, we provided an offer letter to Mr. Somma, which offer letter provides for the basic terms of his employment, including an initial annual base

salary rate of $500,000, a 2022 target STIP opportunity equal to 70% of his base salary, an expected long-term incentive award target of $700,000, and certain customary employee benefits. The offer letter also provides that Mr. Somma will participate in the Severance Plan, which is further described below. The offer letter also provides that Mr. Somma will enter into a restrictive covenant agreement.

In connection with his commencement of employment in January 2021, we provided an offer letter to Mr. Kalter, which offer letter provides for the basic terms of his employment, including an initial annual base salary rate of $375,000, participation in annual and long-term incentive plans, a sign-on payment of $150,000 (paid in 2021), and certain customary employee benefits. The offer letter also provides that Mr. Kalter will participate in the Severance Plan. The offer letter also provides that Mr. Kalter will enter into a restrictive covenant agreement.

Independent Contractor Agreement

In connection with Mr. Fieler’s appointment as I-CFO, which was effective as of December 1, 2023, the Company and Mr. Fieler executed an independent contractor agreement (“ICA”). Pursuant to the terms of the ICA, Mr. Fieler’s appointment was on a month-to-month basis, with the ability for either party to terminate the appointment on not less than 30 days’ notice without cause. Mr. Fieler did not receive any cash compensation for his service as I-CFO. For the duration of Mr. Fieler’s service as interim CFO, Mr. Fieler received monthly compensation in the form of shares of the Company’s common stock valued at $42,500, with the number of shares to be based on the weighted average closing price of the Company’s common stock for the twenty (20) trading days prior to and including the last trading day of each month.

Additionally, Mr. Fieler was eligible for a minimum bonus at the conclusion of his service as interim CFO of $360,000, pro-rated based on the number of months (relative to a full year) in which Mr. Fieler served as I-CFO. The bonus award could be increased up to a value of $720,000 (subject to pro-ration as described above) based on Mr. Fieler’s performance as I-CFO in the discretion of the Compensation Committee. Payment of the bonus, when earned, was to be made in shares, with the number of shares based on the weighted average closing price of the Company’s common stock for the twenty (20) trading days prior to and including the last trading day of the month in which Mr. Fieler’s service as I-CFO ended. Mr. Fieler was not eligible for an annual long-term-incentive grant as his tenure as I-CFO was not expected to exceed twelve months. Mr. Fieler continued to receive his cash and equity compensation as a member of the Board.

Mr. Fieler’s appointment as I-CFO lasted through February 18, 2024, when the Company named its new CFO, Jaime Vasquez. For the duration of his I-CFO service, Mr. Fieler received monthly compensation equal to $42,500 in shares of the Company’s common stock. Additionally, following his I-CFO service, the Compensation Committee approved and Mr. Fieler received a bonus equal to $90,000, paid in 18,181 shares of the Company’s common stock. Mr. Fieler received no further compensation in connection with his appointment as I-CFO.

Separation Agreements

During Mr. Somma’s employment with the Company, he had an offer letter that provided for the basic terms of his employment, including an initial annual base salary rate of $500,000, a 2022 target STI opportunity equal to 70% of his base salary, an expected long-term incentive award target of $700,000, and certain customary employee benefits. The offer letter also provided that Mr. Somma would participate in the Severance Plan. The offer letter also provided that Mr. Somma would enter into a restrictive covenant agreement.

On December 1, 2023, we entered into a Separation Agreement with Lawrence Somma to memorialize the terms of his departure from the Company. The Separation Agreement provided for customary releases of claims in favor of the Company in exchange for the following: a lump sum payment of $300,000; full vesting of all remaining RSUs granted on November 23, 2021, prorated vesting through December 1, 2023, of RSUs granted on March 2, 2022, and March 22, 2023; prorated vesting through December 1, 2023, for non-qualified stock

options granted on March 22, 2023; prorated vesting through December 1, 2023, for performance restricted stock units granted on March 2, 2022, and March 22, 2023, with such vested PSUs subject to the Company’s actual achievement of performance goals for such awards; and reimbursement for the portion of Mr. Somma’s COBRA premiums that exceeds his active employee rates for coverage for him and his dependents for up to 12 months following the separation. The Separation Agreement also includes reaffirmation of Mr. Somma’s obligations under his restrictive covenant agreement.

Tax Considerations

Code Section 162(m) imposes an annual deduction limit of $1 million on the amount of compensation paid to each “covered employee,” which includes certain current and former officers (including the NEOs). Compensation paid to our NEOs over this limit is generally nondeductible. The Compensation Committee structures our executive compensation program so that a sizable portion of total executive compensation is linked to the performance of our Company, even though amounts in excess of the Code Section 162(m) limit are generally not deductible.

Compensation Committee Interlocks and Insider Participation

During the last fiscal year, our Compensation Committee members were Messrs. Bouck and Musa and Ms. Burnell, none of whom served as an officer or employee of the Company or any of our subsidiaries prior to or while serving on the Compensation Committee. During our 2023 fiscal year, no member of the Compensation Committee had a relationship that must be described under SEC rules relating to disclosure of related party transactions and no interlocking relationship existed between our Board or Compensation Committee and the board of directors or compensation committee of any other company.

Compensation Committee Report

The Compensation Committee has reviewed and discussed the foregoing “Compensation Discussion and Analysis” with management and based on such review and discussions, recommended to the Board that the “Compensation Discussion and Analysis” be included in this proxy statement and in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023.

Compensation Committee:

Steve Bouck (Chair)

Tanya Burnell

Fernando Musa

Compensation Tables

2023 Summary Compensation Table

The following table provides information regarding the compensation of our NEOs for the 2023, 2022, and 2021 fiscal years, as applicable.


Name and Principal Position	Fiscal Year		Salary ($)		Bonus ($)		Stock Awards⁽¹⁾ ($)		Option Awards⁽²⁾ ($)		Non-Equity Incentive Plan Compensation⁽³⁾ ($)		All Other Compensation⁽⁴⁾ ($)		Total ($)

Dustin Olson Chief Executive Officer		2023		758,135				2,368,410		494,356		301,470		24,195		3,946,566
		2022		571,355		463,864		3,218,639		—		55,983		13,204		4,323,045
		2021		400,000		721,000		5,547,341		—		—		26,222		6,694,563

Jeffrey Fieler⁵ Interim Chief Financial Officer		2023		—		—		148,620		—		—		100,000		248,620

Lawrence Somma Former Chief Financial Officer		2023		468,269		—		967,104		201,860		—		349,674		1,986,907
		2022		500,000		283,500		851,765		—		36,750		20,595		1,692,610
		2021		64,423		250,000		3,299,996		—		—		1,667		3,616,086

Brad Kalter General Counsel & Corporate Secretary		2023		398,154		—		730,260		152,424		110,839		22,224		1,413,902
		2022		394,792		223,927		608,406		—		29,027		20,938		1,277,090

(1)

Amounts in this column reflect the aggregate grant date fair values of performance-based restricted stock unit (“PSU”), and service-based restricted stock unit (“RSU”) awards granted by the Company to the NEOs (other than Mr. Fieler) in 2023, in each case calculated in accordance with Financial Accounting Standards Board Accounting Standards Codification (“FASB ASC”) Topic 718. For performance-based awards, grant date fair values reflect the value at the grant date based on the probable outcome of the applicable performance conditions. Assuming maximum achievement with respect to the applicable performance conditions, the grant date fair values of the 2023 long-term incentive program PSU awards granted on March 22, 2023, would be as follows: for Mr. Olson, $1,578,936; for Mr. Somma, $644,736; and for Mr. Kalter, $486,840. For information regarding the assumptions used in calculating the value of these awards, see note 5 (Equity-Based Compensation) to the consolidated financial statements contained in our Annual Report on Form 10-K for the year ended December 31, 2023. For more information regarding the awards disclosed in this column, see “Long-Term Incentive Equity Awards” above. For Mr. Fieler, the amount in this column represents his equity retainer for services as a director, which would have otherwise been reported in the “Stock Awards” column of the “2023 Director Compensation Table.”

(2)

Amounts in this column reflect the grant date fair value of the option awards granted by the Company to the NEOs (other than Mr. Fieler) in 2023, calculated in accordance with FASB ASC Topic 718. For information regarding the assumptions used in calculating the value of these awards, see note 5 (Equity-Based Compensation) to the consolidated financial statements contained in our Annual Report on Form 10-K for the year ended December 31, 2023. See the “2023 Grants of Plan-Based Awards” table for more information on these grants.

(3)	Reflects cash incentive amounts paid to the NEOs (other than Mr. Fieler) under the Company’s STI program for 2023, as further described above under “2023 Short-Term Cash Incentive Awards.”

(4)	The chart below provides a breakdown of the amounts reported in All Other Compensation column:


NEO	Director Compensation^(a)		Airline Compensation^(b)		Group Term Life		401(k) Company Match		Executive Physical		Separation Payment^(c)		Total
Dustin Olson		—		—	$	332	$	19,527	$	4,336		—	$	24,195
Jeffrey Fieler	$	100,000		—		—		—		—		—	$	100,000
Lawrence Somma		—	$	750	$	953	$	17,401	$	4,328	$	326,243	$	349,674
Brad Kalter		—		—	$	953	$	17,431	$	3,841		—	$	22,225

(a)

This amount represents the cash retainer fees that Mr. Fieler earned for his service as a director during 2023, which would have otherwise been reported in the “Fees Earned or Paid in Cash” column of the 2023 Director Compensation Table.”

(b)

Represents a fixed cash amount that is paid under our travel and entertainment policy as an incentive to travel in coach for business travel.

(c)

Consists of a cash payment of $300,000 and $26,243 COBRA reimbursement in connection with his separation.

(5)	The compensation reported in this table for Mr. Fieler includes only compensation he received for his services as a director during 2023. For more information about Mr. Fieler’s compensation for his I-CFO role, which is not reportable as 2023 compensation, see, 2023 Key Leadership Changes above.

2023 Grants of Plan-Based Awards

The following table presents additional information regarding plan-based awards granted to our NEOs in fiscal 2023.


Name	Grant Date⁽¹⁾		Estimated Possible Payouts Under Non-Equity Incentive Plan Awards⁽²⁾						Estimated Future Payouts Under Equity Incentive Plan Awards⁽³⁾						All Other Stock Awards: Number of Shares of Stock or Units⁽⁴⁾ (#)		All Other Option Awards: Number of Securities Underlying Options⁽⁵⁾ (#)		Exercise or Base Price of Option Awards⁽⁵⁾ ($/Sh)		Grant Date Fair Value of Stock and Option Awards⁽⁶⁾ ($)
Name	Grant Date⁽¹⁾		Threshold ($)		Target ($)		Maximum ($)		Threshold (#)		Target (#)		Maximum (#)						Exercise or Base Price of Option Awards⁽⁵⁾ ($/Sh)		Grant Date Fair Value of Stock and Option Awards⁽⁶⁾ ($)
Dustin Olson		3/22/2023		275,550		773,000		1,546,000		65,789		131,578		263,156								789,468
		3/22/2023														263,157						1,578,942
		3/22/2023																169,300		5.72		494,356
Jeffrey Fieler		5/10/2023														20,193						148,620
Lawrence Somma		3/22/2023		124,339		355,255		710,510		26,864		53,728		107,456								322,368
		3/22/2023														107,456						644,736
		3/22/2023																69,130		5.72		201,860
Brad Kalter		3/22/2023		99,471		284,204		568,408		20,285		40,570		81,140								243,420
		3/22/2023														81,140						486,840
		3/22/2023																52,200		5.72		152,424

(1)	The Compensation Committee approved the 2023 LTI awards to each of the NEOs on March 22, 2023. The LTI awards are generally subject to continued employment through the applicable performance or vesting period.

(2)	Represent payout opportunities for the NEOs under the 2023 STI program.

(3)	Represents the potential payout for the PSUs granted on March 22, 2023. For the PSUs, threshold payout is 50% of target and maximum payout is 200% of target, and actual payout is based on three-year operational metrics.

(4)

Represents the RSU awards for 2023. RSUs are time-based and do not have a performance requirement for vesting. The time-based awards generally vest 25% per year over 4 years on March 22, 2024, March 22, 2025, March 22, 2026, and March 22, 2027, except for Mr. Fieler’s award, which was granted in connection with his service as a director and vests on the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Company’s regular annual meeting of shareholders which occurs in the calendar year following the calendar year in which the date of grant occurs.

(5)	Represents the number of Options awarded on the grant date, which cliff vest at the end of a three-year period on March 22, 2026.

(6)	Represents the grant date fair value, calculated in accordance with FASB ASC Topic 718, based on the closing price of our stock on the date of grant for RSUs and PSUs and a Black-Scholes value for Options. The values reported in this column for the PSUs were calculated at target.

Outstanding Equity Awards at 2023 Fiscal Year-End

The following table summarizes information about all outstanding unvested equity awards held by our NEOs as of December 29, 2023.


			Option Awards										Stock Awards
Name	Grant Date		Number of Securities Underlying Unexercised Options Exercisable (#)			Number of Securities Underlying Unexercised Options Unexercisable (#)			Option Exercise Price ($)		Option Expiration Date		Number of Shares or Units of Stock That Have Not Vested (#)			Market Value of Shares or Units of Stock That Have Not Vested⁽¹⁾ ($)		Equity Incentive Plan Awards: Number of Unearned Shares, Units, or Other Rights That Have Not Vested (#)			Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units, or Other Rights That Have Not Vested⁽¹⁾ ($)

Dustin Olson		1/4/2021												38,793	⁽²⁾		157,112
		7/8/2021												90,305	⁽³⁾		365,735
		3/2/2022																	58,823	^(5a)		238,233
		3/2/2022												44,118	^(5b)		178,678
		5/20/2022																	21,766	^(5a)		88,152
		5/20/2022												16,325	^(6a)		66,116
		8/5/2022																	113,332	^(5a)		458,995
		8/5/2022												84,999	^(6b)		344,246
		3/22/2023		0			169,300	^(7a)		5.72		3/22/2033
		3/22/2023																	131,578	^(7b)		532,891
		3/22/2023												263,157	^(7c)		1,065,786

Jeffrey Fieler		5/10/2023												20,193	⁽⁸⁾		81,782

Lawrence Somma⁽⁴⁾		3/2/2022																	37,603	^(5a)		152,292
		3/22/2023		16,035	^(7d)		0			5.72		2/29/2024
		3/22/2023																	16,437	^(7b)		66,570

Brad Kalter		7/8/2021												37,507	⁽³⁾		151,903
		3/2/2022																	42,017	^(5a)		170,169
		3/2/2022												31,513	^(5b)		127,628
		3/22/2023		0			52,200	^(7a)		5.72		3/22/2033
		3/22/2023																	40,570	^(7b)		164,309
		3/22/2023												81,140	^(7c)		328,617

(1)	Based on the closing stock price of $4.05 on December 29, 2023.

(2)	Reflects restricted shares received in satisfaction of the incentive units granted by PureCycle Technologies LLC to Mr. Olson prior to the Company going public, 25% of which vested on January 4, 2022, and 1/36 of which vest on a monthly basis thereafter.

(3)

RSUs awarded on July 8, 2021,vest at the rate of 25% per year, subject to satisfaction of vesting criteria for the applicable year, with vesting dates of July 8, 2022, July 8, 2023, July 8, 2024, and July 8, 2025. LTI awards are generally subject to continued employment through the applicable vesting date.

(4)

Mr. Somma was awarded RSUs on November 23, 2021, vest at the rate of 25% per year, subject to satisfaction of vesting criteria for the applicable year, with vesting dates of November 15, 2022, November 15, 2023, November 15, 2024, and November 15, 2025. In accordance with Mr. Somma’s separation agreement, the remaining RSUs granted on November 23, 2021,fully vested on December 29, 2023.

(5a)

PSUs awarded to Mr. Olson and Mr. Kalter on March 2, 2022 and to Mr. Olson on May 20, 2022, and August 5, 2022, become eligible to vest upon Compensation Committee certification of achievement of performance metrics for the three-year performance period ending on December 31, 2024. LTI awards are generally subject to continued employment through the applicable vesting period. Mr. Somma’s PSUs were prorated based on his December 1, 2023,resignation date.

(5b)

RSUs awarded on March 2, 2022, vest at the rate of 25% per year, subject to satisfaction of vesting criteria for the applicable year, with vesting dates of March 2, 2023, March 2, 2024, March 2, 2025, and March 2, 2026. LTI awards are generally subject to continued employment through the applicable vesting date.

(6a)

RSUs awarded on May 20, 2022,vest at the rate of 25% per year, subject to satisfaction of vesting criteria for the applicable year, with vesting dates of May 20, 2023, May 20, 2024, May 20, 2025, and May 20, 2026. LTI awards are generally subject to continued employment through the applicable vesting date.

(6b)

RSUs awarded on August 5, 2022,vest at the rate of 25% per year, subject to satisfaction of vesting criteria for the applicable year, with vesting dates of August 5, 2023, August 5, 2024, August 5, 2025, and August 5, 2026. LTI awards are generally subject to continued employment through the applicable vesting date.

(7a)	Non-qualified options awarded on March 22, 2023,cliff vest on March 22, 2026, and expire in 2033.

(7b)

PSUs awarded on March 22, 2023,become eligible to vest upon Compensation Committee certification of achievement of performance metrics for the three-year performance period ending on December 31, 2025. LTI awards are generally subject to continued employment through the applicable vesting period. Mr. Somma’s PSU opportunities were prorated based on his December 1, 2023,resignation date.

(7c)

RSUs awarded on March 22, 2023,vest at the rate of 25% per year, subject to satisfaction of vesting criteria for the applicable year, with vesting dates of March 22, 2024, March 22, 2025, March 22, 2026, and March 22, 2027. LTI awards are generally subject to continued employment through the applicable vesting date.

(7d)	A prorated portion of Mr. Somma’s non-qualified stock option (based on his December 1, 2023,resignation date) vested in connection with his departure and remained exercisable for 90 days after his resignation.

(8)

Reflects RSUs granted in connection with Mr. Fieler’s service as a director that vest on the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Company’s regular annual meeting of shareholders which occurs in the calendar year following the calendar year in which the date of grant occurs.

2023 Option Exercises and Stock Vested

The following table provides details regarding the equity awards held by our NEOs that vested during 2023.


Name	Option Awards			Stock Awards
Name	Number of Shares Acquired on Exercise (#)		Value Realized on Exercise ($)	Number of Shares Acquired on Vesting (#)		Value Realized on Vesting ($)

Dustin Olson		—			129,441	$	1,170,078	^{(1)(2)(3)(4)(7)}

Jeffrey Fieler		—			13,447		104,349	⁽⁸⁾

Lawrence Somma		—			225,625		946,533	⁽⁵⁾⁽⁶⁾

Brad Kalter		—			29,257	$	257,814	⁽¹⁾⁽³⁾

(1)	The value realized on vesting of stock awards includes RSUs that vested on March 2, 2023, based on a market value of $5.62 for all NEOs (other than Mr. Fieler).

(2)	The value realized on vesting of stock awards includes RSUs that vested on May 20, 2023, based on a market value of $6.60 for Mr. Olson.

(3)	The value realized on vesting of stock awards includes RSUs that vested on July 8, 2023, based on a market value of $10.60 for Mr. Olson and Mr. Kalter.

(4)	The value realized on vesting of stock awards includes RSUs that vested on August 5, 2023, based on a market value of $10.97 for Mr. Olson.

(5)	The value realized on vesting of stock awards includes RSUs that vested on November 15, 2023, based on a market value of $4.21 for Mr. Somma.

(6)	The value realized on vesting of stock awards includes RSUs that vested on December 29, 2023, based on a market value of $4.05 for Mr. Somma.

(7)

The value realized on vesting of stock awards for Mr. Olson also includes restricted shares received in satisfaction of the incentive units granted by PureCycle Technologies LLC to Mr. Olson prior to the Company going public, a portion of which vested on January 4, 2022, and which continued to vest monthly thereafter.

(8)	The value realized on vesting of stock awards includes Mr. Fieler’s director RSUs awarded in 2022 that vested on May 10, 2023, based on a market value of $7.76.

Potential Payments Upon Termination or Change in Control

As discussed above in “2023 Key Leadership Changes”, Mr. Fieler’s I-CFO compensation structure reflected the temporary nature of his role during the leadership transition months rather than an executive compensation package designed to attract and retain his services long term. Consequently, he was not eligible to participate in the severance plan described below; as a result none of the severance compensation discussions below are applicable to Mr. Fieler.

Severance and Change in Control Compensation

Severance Plan

In May 2021, the Company adopted the Severance Plan, which covers certain officers of the Company, including the continuing NEOs. Under the Severance Plan, if an NEO’s employment is terminated by the Company without “cause” or by the NEO for “good reason” (as such terms are defined in the Severance Plan) other than within 12 months following a “change in control” (as defined in the Severance Plan), the Company will pay the NEO severance payments in installments equal in the aggregate to one year of base salary and will reimburse the NEO for COBRA continuation coverage premiums for up to 12 months to the extent they exceed the premiums paid by the NEO for such coverage immediately prior to the date of termination (the “COBRA Reimbursement”).

If a NEO’s employment is terminated by the Company without cause or by the NEO for good reason within 12 months following a change in control, the Company will pay the NEO a lump sum cash severance amount equal to the sum of (a) 1.5 times the NEO’s annual base salary rate (determined in accordance with the Severance Plan) plus (b) 1.5 times the NEO’s short-term annual cash incentive target for the year in which the termination of employment occurs. In such case, the Company will also provide the COBRA Reimbursement and any outplacement services or outplacement reimbursement to which the NEO would have been entitled in connection with the NEO’s termination of employment under any plan, program, or arrangement of the Company immediately prior to the change in control. Further, any equity awards held by the NEO would vest in full upon such termination of employment, with performance-based awards vesting at target.

If a NEO is entitled to cash severance under both his employment agreement and the Severance Plan upon his termination of employment, he will receive only the cash severance payments under the applicable arrangement that will provide him with the greatest cash severance value, and will not be entitled to cash severance under the other arrangement.

Participation in the Severance Plan is generally contingent upon the NEO signing an agreement providing for customary post-employment non-competition, employee and customer non-solicitation, and confidentiality provisions. Except as otherwise determined by the Compensation Committee, participation in the Severance Plan is also contingent upon employment by the Company for a period of at least six continuous months prior to participation in the Severance Plan. Payment of the severance amounts under the Severance Plan is generally subject to the NEO’s execution of a customary release of claims in favor of the Company.

The Board (or an authorized committee of the Board) may amend or terminate the Severance Plan, provided that written notice of any amendment or termination must be provided to participants not less than 60 days prior to the effective date of such amendment or termination. The Severance Plan will automatically terminate on the second anniversary following the first change in control to occur under the Severance Plan. However, no amendment reducing the severance benefits provided under the Severance Plan or terminating the Severance Plan may be effective prior to the 12-month anniversary of the effective date of the Severance Plan, and the Board will not amend or terminate the Severance Plan at any time after (1) the occurrence of a change in control or (2) the date we enter into a definitive agreement which, if consummated, would result in a change in control, unless the potential change in control is abandoned (as publicly announced by the Company), in either case until twenty-four (24) months after the occurrence of a change in control. Further, no such amendment or termination will operate to reduce severance benefits payable with respect to a separation from service that occurs prior to the effective date of such amendment or termination.

Equity Compensation

In general, RSUs and PSUs granted under our long-term incentive program are eligible to vest as follows in the event of certain termination and change in control scenarios.

RSUs. If an NEO’s employment is terminated by the Company without “cause” or by the NEO for “good reason” (as each such term is defined in the applicable award agreement), then any unvested RSUs will vest on a pro-rata basis based on the NEO’s period of service from the grant date until the date of the termination of employment. If an NEO’s employment is terminated due to death or disability, the RSUs will vest in full.

If an NEO remains employed through the date of a “change in control” (as defined for purposes of the applicable equity awards) and a replacement award is not provided, the RSUs will vest in full. If a replacement award is provided and, at any point within twelve months following a “change in control,” the employment of an NEO is terminated by the Company (or its successor) without “cause” or by the NEO for “good reason,” unvested RSUs held by the NEO will vest in full.

PSUs. If an NEO’s employment is terminated by the Company without “cause” or by the NEO for “good reason,” prior to end of the applicable performance period, a pro-rata portion of the PSUs shall remain outstanding and eligible to vest based on actual performance achievement for the full performance period, with such pro-rata portion determined based on the NEO’s period of service during the performance period. If an NEO’s employment is terminated due to death or disability, a pro-rata portion of the PSUs will immediately vest (with any applicable performance goals that have not yet been scored deemed to have been attained at the target level), with such pro-rata portion determined based on the NEO’s period of service during the performance period.

If an NEO remains employed through the date of a “change in control” (as defined for purposes of the applicable equity awards) and a replacement award is not provided, the PSUs will vest in full (with any applicable performance goals that have not yet been scored deemed to have been attained at the target level). If a replacement award is provided and, within twelve months following a “change in control,” the employment of an NEO is terminated by the Company (or its successor) without “cause” or by the NEO for “good reason,” all PSUs will immediately vest (with any applicable performance goals that have not yet been scored deemed to have been attained at the target level).

Non-qualified options. If an NEO’s employment is terminated by the Company without “cause” or by the NEO for “good reason” prior to the end of the vesting period, a pro-rata portion of the option will vest, with such pro-rata portion determined based on the NEO’s period of service from the grant date until the date of termination of employment. If an NEO’s employment is terminated due to death or disability, the unvested portion of the option will vest in full upon termination.

If an NEO remains employed through the date of a “change in control” (as defined for purposes of the applicable equity awards) and a replacement award is not provided, the option will vest in full. If a replacement award is provided and, at any point within twelve months following a “change in control,” the employment of an NEO is terminated by the Company (or its successor) without “cause” or by the NEO for “good reason,” the replacement award will vest in full.

Director RSUs. With respect to the unvested director RSU awards that Mr. Fieler held as of the end of the 2023 fiscal year, such awards would vest in the event he ceases service due to death/disability or in the event of a “change in control.” The value of the accelerated vesting of such awards based on an assumed triggering date (for such death/disability or change in control) of December 29, 2023, would be $81,782.

The tables below show the payments and benefits potentially payable to each of our NEOs who were employed by the Company at the end of the 2023 fiscal year upon the NEO’s death or disability, termination of employment without cause or for good reason (other than in connection with a change in control), or termination without cause or for good reason in connection with a change in control, in each case based on an assumed termination date of December 29, 2023, (other than with respect to Mr. Somma, for whom the actual amounts received in connection with his separation from the Company are set forth below such tables and Mr. Fieler, for whom the only benefit would be accelerated vesting of his director RSUs awarded in May 2023 as described and quantified in the narrative above). The employment of the NEOs in the tables below did not actually terminate on December 29, 2023. The actual amounts to be paid to such NEOs in connection with their termination of employment can only be determined at the time of such termination and will depend on the circumstances of such termination.


Dustin Olson	Voluntary Resignation or Involuntary Termination for Cause		Death or Disability			Termination by the Company without Cause or by NEO for Good Reason (other than within 12 months after CIC)			Termination by the Company without Cause or by the NEO for Good Reason (within 12 months after CIC)

Salary		N/A		N/A		$	773,000	⁽¹⁾	$	1,159,500	⁽²⁾

STI		N/A	$	301,470	⁽³⁾		N/A		$	1,159,500	⁽⁴⁾

PSU		N/A	$	701,217	⁽⁵⁾	$	1,318,271	⁽⁶⁾	$	1,035,962	⁽⁷⁾

RSU		N/A	$	2,020,561	⁽⁸⁾	$	1,340,287	⁽⁹⁾	$	1,654,826	⁽¹⁰⁾

Options		N/A	$	685,665	⁽¹¹⁾	$	178,459	⁽¹²⁾	$	685,665	⁽¹¹⁾

Benefits		N/A		N/A		$	20,822	⁽¹³⁾	$	20,822	⁽¹³⁾

Total		N/A	$	3,708,913		$	3,360,839		$	5,716,274


Brad Kalter	Voluntary Resignation or Involuntary Termination for Cause		Death or Disability			Termination by the Company without Cause or by NEO for Good Reason (other than within 12 months after CIC)			Termination by the Company without Cause or by the NEO for Good Reason (within 12 months after CIC)

Salary		N/A		N/A		$	408,000	⁽¹⁾	$	612,000	⁽²⁾

STI		N/A	$	110,839	⁽³⁾		N/A		$	428,400	⁽⁴⁾

PSU		N/A	$	168,215	⁽⁵⁾	$	344,477	⁽⁶⁾	$	334,477	⁽⁷⁾

RSU		N/A	$	608,148	⁽⁸⁾	$	436,878	⁽⁹⁾	$	608,148	⁽¹⁰⁾

Options		N/A	$	211,410	⁽¹¹⁾	$	55,023	⁽¹²⁾	$	211,410	⁽¹¹⁾

Benefits		N/A		N/A		$	14,908	⁽¹³⁾	$	14,908	⁽¹³⁾

Total		N/A	$	1,098,612		$	1,249,286		$	2,209,343

(1)	1 times current base salary.

(2)	1.5 times current base salary.

(3)

Reflects lump sum cash payment (payable only in the event of death, not disability) equal to annual STI that would have been earned for the calendar year of termination based on actual performance achievement for the full performance year, pro-rated based on the executive’s period of service during such year.

(4)	1.5 times the NEO’s short-term annual cash incentive target for the year in which the termination of employment occurs.

(5)	Represents the accelerated vesting of all unvested PSUs (at target performance level) prorated based on period of service from performance period start date to termination date.

(6)	Represents the unvested PSUs (at assumed target performance level). Unvested PSUs remain outstanding and are eligible to vest based on actual performance achievement for the full performance period to be prorated based on period of service during the performance period.

(7)	Represents the accelerated vesting of all unvested PSUs (at target performance level) based on the closing price of the common stock on 12/29/23.

(8)	Represents the accelerated vesting of all unvested RSUs.

(9)	Represents the accelerated vesting of all unvested RSUs prorated from grant date to termination date.

(10)	Represents the accelerated vesting of all unvested RSUs based on closing price of the common stock on 12/29/23.

(11)	Represents the accelerated vesting of all unvested Options.

(12)	Represents the accelerated vesting of all unvested Options prorated from grant date to termination date.

(13)	The estimated Company cost of COBRA reimbursements for 12 months.

(14)	Inapplicable to Mr. Fieler. For more information about Mr. Fieler’s compensation for his I-CFO role, see, 2023 Key Leadership Changes above.

Separation Arrangement with Mr. Somma

Pursuant to his Separation Agreement, Mr. Somma received a cash payment of $300,000, full vesting of the remaining 120,791 RSUs that were part of an award granted to him upon joining the Company in November 2021 valued at $489,204, pro-rated vesting of his outstanding RSUs (valued at $120,419), pro-rata vesting of his outstanding stock options valued at $66,570, (based on spread value of the portion of such vesting stock options that were “in the money” at the time of vesting) the eligibility to vest pro-rata in his outstanding PSUs based on achievement of the applicable performance goals valued at $64,942, (assuming target performance),and up to 12 months of partial reimbursements for COBRA coverage valued at $26,243.

Securities Authorized for Issuance Under Equity Compensation Plans

The following table provides information as of December 31, 2023, regarding the Company’s compensation plans under which the Company’s equity securities are authorized for issuance.

Equity Compensation Plan Information


Plan Category	Number of securities to be issued upon exercise of outstanding options, warrants and rights⁽¹⁾ (a)		Weighted-average exercise price of outstanding options, warrants and rights⁽²⁾ (b)		Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a))⁽³⁾ (c)
Equity compensation plans approved by security holders		5,878,396	$	20.17		9,625,402
Equity compensation plans not approved by security holders		—		—		—

TOTAL		5,878,396	$	20.17		9,625,402

(1)

Reflects options and rights outstanding under the PureCycle Technologies, Inc. 2021 Equity and Incentive Compensation Plan (the “2021 Plan”). Performance-based restricted stock unit awards are reflected in this column assuming maximum performance with respect to the applicable performance goals, which may overstate potential dilution with respect to such awards.

(2)	The weighted-average exercise price relates to outstanding stock options only. The Company’s restricted stock unit awards have no exercise price.

(3)

As of December 31, 2023, consists of the shares available for future issuance under the 2021 Plan, all of which may be issued for awards other than options, warrants or rights (such as restricted stock). In general, the aggregate share limit under the 2021 Plan will be automatically increased on the first day of each fiscal year, until 2031, by an amount equal to the lesser of (a) 3% of the shares of the Company’s common stock outstanding on the last day of the immediately preceding fiscal year and (b) such smaller number of shares as determined by the Board of Directors of the Company.

CEO Pay Ratio

The “CEO Pay Ratio” is a comparison of the CEO’s annual total compensation to the annual total compensation of our median employee (referred to herein as the “Median Employee”). CEO compensation for purposes of this disclosure represents the total compensation reported for Mr. Olson in the 2023 Summary Compensation Table above. The total annual compensation for each of Mr. Olson and our Median Employee, as well as the ratio, is set forth below:

•

Mr. Olson’s annual total compensation for 2023 (as described above) was $3,946,566.

•

PCT’s Median Employee annual total compensation was $127,672.

•

The ratio of CEO annual total compensation to Median Employee annual total compensation for 2023 was approximately 31 to 1.

To identify the median employee, we conducted an analysis of our total U.S. employee population that were active employees as of December 31, 2023, without the use of statistical sampling. We determined our median employee using “total compensation” paid during the full year 2023. Total compensation consisted of gross wages to include base wages, overtime, shift differential, incentives, paid time off, and perquisites, as applicable. We did not annualize gross wages for employees who were not employed for the full year in 2023.

This pay ratio is a reasonable estimate calculated in a manner consistent with Item 402(u) of Regulation S-K of the SEC using the data and methodology summarized above. The SEC rules for identifying the median compensated employee allow companies to adopt a variety of methodologies, to apply certain exclusions, and to make reasonable estimates and assumptions that reflect their compensation practices. As such, the median employee compensation amount and CEO pay ratio reported by other companies may not be comparable to the amount and ratio reported above.

Pay versus Performance

The table below discloses the total compensation for our NEOs for the past three fiscal years as disclosed in the Summary Compensation Table, the “compensation actually paid” to our principal executive officer (our “PEO”) and, on an average basis, our other NEOs (in each case, as determined under SEC rules) (collectively, the “PVP NEOs”), our total shareholder return (“TSR”), the TSR of the S&P Small Cap 600 Materials Index over the same period, our net income, and our company-selected financial performance measure, Adjusted EBITDA.


PAY VERSUS PERFORMANCE TABLE
Year(a)	Summary Compensation Table Total for PEO 1 (b)(1)		Compensation Actually Paid to PEO 1 (c)(1)(2)		Summary Compensation Table Total for PEO 2 (b)(1)		Compensation Actually Paid for PEO 2 (c)(1)(2)			Average Summary Compensation Table Total for Non-PEO Named Executive Officers (d)(1)		Average Compensation Actually Paid to Non-PEO Named Executive Officers (e)(1)(2)		Value of Initial Fixed $100 Investment Based On:				Net Income (Losses) (in thousands) (h)			Company- Selected Measure: Adjusted EBITDA (in thousands) (i)(4)
Year(a)	Summary Compensation Table Total for PEO 1 (b)(1)		Compensation Actually Paid to PEO 1 (c)(1)(2)		Summary Compensation Table Total for PEO 2 (b)(1)		Compensation Actually Paid for PEO 2 (c)(1)(2)							Total Shareholder Return (f)(3)		Peer Group Total Shareholder Return (g)(3)		Net Income (Losses) (in thousands) (h)

2023	$	3,946,566	$	3,084,231						$	1,216,476	$	210,388	$	14.01		115.92	($	101,715	)	($	84,893	)

2022	$	4,323,045	$	1,911,537	$	4,266,831	($	4,574,715	)	$	1,313,331	$	245,344	$	23.39	$	96.62	($	84,746	)	($	61,745	)

2021		—		—	$	9,352,652	$	7,655,192		$	14,889,283	$	7,444,210	$	33.11	$	102.88	($	77,502	)	($	40,584	)

(1)

Dustin Olson (“PEO 1”) served as our principal executive officer starting August 5, 2022. Michael Otworth (“PEO 2” and, together with PEO 1, the “PEOs”) served as our principal executive officer from January 1, 2022, through August 4, 2022, and for all of 2021. For 2023, our

non-PEO

NEOs were Lawrence Somma, Jeffrey Fieler and Brad Kalter. For 2022, our

non-PEO

NEOs were Lawrence Somma, Brad Kalter and David Brenner. For 2021, our

non-PEO

NEOs were Lawrence Somma, Michael Dee and Dustin Olson. In this disclosure, we refer to each of 2023, 2022 and 2021 as a “Covered Year.”

(2)	For each of 2023, 2022 and 2021, the values included in this column for the CAP to our PEOs and the average CAP to our non-PEO NEOs reflect the following adjustments to the values included in column (b) and column (d), respectively:


PEO 1 (Dustin Olson)	2023 ($)

Summary Compensation Table Total for PEO (column (b))		3,946,566

- aggregate change in actuarial present value of pension benefits		0

+ service cost of pension benefits		0

+ prior service cost of pension benefits		0

- SCT “Stock Awards” column value		(2,368,410	)

- SCT “Option Awards” column value		(494,356	)

+year-end fair value of equity awards granted in the Covered Year that are outstanding and unvested as of the Covered Year-end		1,826,587

+/- change in fair value (from prior year-end to Covered Year-end) of equity awards granted in prior years that are outstanding and unvested as of the Covered Year-end		(15,935	)

+ vesting date fair value of equity awards granted and vested in the Covered Year		0

+/- change in fair value (from prior year-end to vesting date) of equity awards granted in prior years that vested in the Covered Year		312,182

- fair value as of prior-year end of equity awards granted in prior years that failed to vest in the Covered Year		(122,403	)

+ dollar value of dividends/earnings paid on equity awards in the Covered Year		0

+ excess fair value for equity award modifications		0

Compensation Actually Paid to PEO 1 (column (c))		3,084,231

Table of Contents


AVERAGE FOR NON-PEO NEOS	2023 ($)

Average SCT Total for Non-PEO NEOs (column (d))		1,216,476

- aggregate change in actuarial present value of pension benefits		0

+ service cost of pension benefits		0

+ prior service cost of pension benefits		0

- SCT “Stock Awards” column value		(615,328	)

- SCT “Option Awards” column value		(118,095	)

+year-end fair value of equity awards granted in the Covered Year that are outstanding and unvested as of the Covered Year-end		463,611

+/- change in fair value (from prior year-end to Covered Year-end) of equity awards granted in prior years that are outstanding and unvested as of the Covered Year-end		1,787

+ vesting date fair value of equity awards granted and vested in the Covered Year		0

+/- change in fair value (from prior year-end to vesting date) of equity awards granted in prior years that vested in the Covered Year		(182,888	)

- fair value as of prior-year end of equity awards granted in prior years that failed to vest in the Covered Year		(555,176	)

+ dollar value of dividends/earnings paid on equity awards in the Covered Year		0

+ excess fair value for equity award modifications		0

Average Compensation Actually Paid to Non-PEO NEOs (column (e))		210,388

(3)

For each of 2023, 2022 and 2021, TSR for the Company and the peer group was calculated as the yearly percentage change in cumulative total shareholder return applied to a deemed fixed investment of $100 at market close on March 17, 2021, the day immediately prior to the first date on which the Company’s securities were registered under Section 12 of the Exchange Act. The yearly percentage change in cumulative TSR was measured as the quotient of (a) the sum of (i) the cumulative amount of dividends for the period from March 17, 2021,through and including the last day of the Covered Year (the “Measurement Period”), assuming dividend reinvestment, plus (ii) the difference between stock price per share at the end and the beginning of the Measurement Period, divided by (b) stock price per share at the beginning of the Measurement Period. For purposes of this PVP disclosure, our peer group is the S&P Small Cap 600 Materials index, which we use for purposes of the performance graph in our annual report (the “Peer Group”). Because fiscal years are presented in the table in reverse chronical order (from top to bottom), the table should be read from bottom to top for purposes of understanding cumulative returns over time.

(4)	Adjusted EBITDA means earnings before income, taxes, depreciation and amortization, less bonus expense and share-based compensation expense.

SEC Form DEF 14A filed by PureCycle Technologies Inc.